Section 50

EurekaMag Full Text Articles Chapter 49,470


Holub, J.; Vinsova, N.; Boswart, J. 1962: Level of GOT and GPT transaminases in different pathological conditions in children. I. Newborn infants. Ceskoslovenska Gynekologie 27: 643-650
Orziev, Z.M.; Nurbaev, F.E.; Rakhimova, G.S. 2003: Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs. Klinicheskaia Meditsina 81(10): 34-36
Schindl, M.; Schoppmann, S.F.; Ströbel, T.; Heinzl, H.; Leisser, C.; Horvat, R.; Birner, P. 2003: Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(2): 779-785
Myśliwska, J.; Bryl, E.; Chodnik, T.; Foerster, J.; Myśliwski, A. 1992: Level of NK cytotoxic activity in the elderly aged more than 80 years. Archives of Gerontology and Geriatrics 15(1): 21-28
Miller, J.L. 2004: Level of RN educational preparation: its impact on collaboration and the relationship between collaboration and professional identity. Canadian Journal of Nursing Research 36(2): 132-147
Schultze, B.; Maurer, W. 1963: Level of RNA synthesis in the nucleolus and karyoplasm in some cell types in mice. Zeitschrift für Zellforschung und mikroskopische Anatomie 60: 387-391
Infante, J.R.; Martínez, A.; Ochoa, J.; Cañadillas, F.; Torres-Avisbal, M.; Vallejo, J.A.; González, F.M.; Pacheco, C.; Latre, J.M. 2003: Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies. Revista Espanola de Medicina Nuclear 22(4): 238-243
Freeman, W. 1953: Level of achievement after lobotomy; a study of one thousand cases. American Journal of Psychiatry 110(4): 269-276
Punnam, S.R.; Jundi, M.; Abolhassani, M.; Badhesa, D.; Padgaonkar, M.; Rana, A. 2005: Level of adherence to National Cholesterol Education Program (NCEP); Adult Treatment Panel III Guidelines: are we doing it right?. Preventive Cardiology 8(1): 65-66
Anderson, C.E.; Lee, A.J.; McLaren, K.M.; Cairns, S.; Cowen, C.; McQueen, F.; Mayer, N.J.; Kamel, H.M. 2004: Level of agreement and biopsy correlation using two- and three-tier systems to grade cervical dyskaryosis. Cytopathology: Official Journal of the British Society for Clinical Cytology 15(5): 256-262
Garcia-Munitis, P.; Bandeira, M.; Pistorio, A.; Magni-Manzoni, S.; Ruperto, N.; Schivo, A.; Martini, A.; Ravelli, A. 2006: Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis and Rheumatism 55(2): 177-183
Hilarius, D.L.; Kloeg, P.H.A.M.; Detmar, S.B.; Muller, M.J.; Aaronson, N.K. 2007: Level of agreement between patient self-report and observer ratings of health-related quality of life communication in oncology. Patient Education and Counseling 65(1): 95-100
Piper, W.E.; Ogrodniczuk, J.S.; Lamarche, C.; Hilscher, T.; Joyce, A.S. 2005: Level of alliance, pattern of alliance, and outcome in short-term group therapy. International Journal of Group PsychoTherapy 55(4): 527-550
Aboobaker, V.S.; Sahasrabudhe, M.B. 1961: Level of alpha-ketoglutaric, beta-hydroxybutyric and succinic oxidases in host livers of tumour-bearing mice. Journal of Scientific and Industrial Research. C Biological Sciences 20c: 1-3
Linhard 1953: Level of anti-A and anti-B isoagglutinins in African Negroes in the region of Dakar. Revue d'Hematologie 8(2): 171-182
Morimoto, T.; Takanashi, S.; Hasegawa, Y.; Fujimoto, K.; Okudera, K.; Hayashi, A.; Taima, K.; Okumura, K. 2006: Level of antibodies against mycobacterial glycolipid in the effusion for diagnosis of tuberculous pleural effusion. Respiratory Medicine 100(10): 1775-1780
Neubauer, E.; Por, F. 1959: Level of antidiuretic hormone in the blood of diabetes insipidus patients in liver disorders. Casopis Lekaru Ceskych 98: 1006-1008
Robbins, P.R. 1963: Level of anxiety, interference proneness, and defensive reactions to fear-arousing information. Journal of Personality 31: 163-178
Venables, P.H.; Wing, J.K. 1962: Level of arousal and the subclassification of schizophrenia. Archives of General Psychiatry 7: 114-119
Fabianek, J. 1961: Level of ascorbic acid in the organs of guinea pigs fed with a diet of well-defined composition. Archives des Sciences Physiologiques 15: 141-153
Starbuck, W.H. 1963: Level of aspiration. Psychological Review 70: 51-60
Siegel, S. 1957: Level of aspiration and decision making. Psychological Review 64(4): 253-262
Parker, S.; Kleiner, R.J.; Taylor, H.G. 1960: Level of aspiration and mental disorder: a research proposal. Annals of the new York Academy of Sciences 84: 878-886
Norman, R.P. 1963: Level of aspiration and social desirability in chronic schizophrenics. Journal of Consulting Psychology 27: 40-44
Raifman, I. 1957: Level of aspiration in a group of peptic ulcer patients. Journal of Consulting Psychology 21(3): 229-231
O'connell, D.D.; Lundy, R.M. 1961: Level of aspiration in hypertensive cardiac patients compared with nonhypertensive cardiac patients with arteriosclerotic heart disease. Journal of Consulting Psychology 25: 353-359
Berkeley, A.W. 1952: Level of aspiration in relation to adrenal cortical activity and the concept of stress. Journal of Comparative and Physiological Psychology 45(5): 443-449
Sheehan, J.G.; Zelen, S.L. 1955: Level of aspiration in stutterers and nonstutterers. Journal of Abnormal Psychology 51(1): 83-86
Lachman, S.J. 1961: Level of aspiration: a classroom demonstration of phenomena and principles. Journal of General Psychology 65: 357-363
Zhang, W.-r.; Hou, F.-f.; Ning, J.-p.; Yang, X.-b.; Wu, Q.; Tao, L.-j.; Chen, B.-m.; Li, H.-y.; Chang, L. 2006: Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease. Zhong Nan da Xue Xue Bao. Yi Xue Ban 31(5): 621-628
Singh, P.; Kumar, A.; Pandey, C.M.; Chandra, H. 2002: Level of awareness about transplantation, brain death and cadaveric organ donation in hospital staff in India. Progress in Transplantation 12(4): 289-292
Terzioglu, M.; Oezer, F.; Gokhan, N. 1956: Level of bicarbonate and chloride ions in plasma and blood cells in human blood at the height of 1850 meters. Minerva Medica 47(53): 14-16
Minarikova, E. 1957: Level of blood bilirubin in premature infants. Ceskoslovenska Pediatrie 12(7): 606-610
Wiwanitkit, V. 2005: Level of blood creatinine in the recent reported cases of bird flu infection in Thailand and Vietnam. Nephrology 10(4): 425
Daum, S. 1951: Level of blood iron and copper in the course of pregnancy. Ceskoslovenska Gynekologie 16(1): 48-56
Lembrych, S. 1959: Level of blood sugar in women following delivery of unusually large infants. Ginekologia Polska 30: 479-482
Floch, H.; Lecuiller, A.; Destombes, P. 1951: Level of blood sulfone following sulfone injections in oil suspension. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 44(7-8): 401-405
Quattrin, R.; Zanini, A.; Nascig, E.; Annunziata, M.; Calligaris, L.; Brusaferro, S. 2006: Level of burnout among nurses working in oncology in an Italian region. Oncology Nursing Forum 33(4): 815-820
Efimova, L.P.; Shitt, T.I.; Mironova, L.A. 2004: Level of cation proteins in blood neutrophils of healthy individuals and patients with arterial hypertension residing in the North. Klinicheskaia Laboratornaia Diagnostika 4: 24; 33-34
Skalicky, J. 1962: Level of chorionic gonadotropic hormone and pregnanediol in the urine of normal pregnant women and in late gestoses. Ceskoslovenska Gynekologie 27: 83-88
Lee, H.B.; Kasper, J.D.; Shore, A.D.; Yokley, J.L.; Black, B.S.; Rabins, P.V. 2006: Level of cognitive impairment predicts mortality in high-risk community samples: the memory and medical care study. Journal of Neuropsychiatry and Clinical Neurosciences 18(4): 543-546
Benvenuto-Andrade, C.; Dusza, S.W.; Hay, J.L.; Agero, A.L.C.; Halpern, A.C.; Kopf, A.W.; Marghoob, A.A. 2006: Level of confidence in diagnosis: clinical examination versus dermoscopy examination. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 32(5): 738-744
Bloch, V. 1951: Level of cutaneous resistance and its relation to psycho-galvanic reaction; study on double derivation. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 145: 1619-1622
Piccinini, F.; Meli, A.; Parenti, M.A.; Capraro, V. 1957: Level of cystine in the pancreas of animals treated with alloxan. Bollettino della Societa Italiana di Biologia Sperimentale 33(10-11): 1421-1423
Nowak-Starz, G. 2002: Level of development of selected somatic features of children at the age of 6 from the Swietokrzyskie region depending on their biological state in their infancy. Wiadomosci Lekarskie 55(Suppl 1): 364-369
Rai, S.; Moster, M.R.; Kesen, M.; Fontanarosa, J.; Spaeth, G.L.; Steinmann, W.C.; Wilson, R.; Myers, J.; Henderer, J. 2005: Level of disagreement between Proview phosphene tonometer and Goldmann applanation tonometer intraocular pressure readings. Journal of Glaucoma 14(2): 120-123
Siukosaari, P.; Ainamo, A.; Närhi, T.O. 2005: Level of education and incidence of caries in the elderly: a 5-year follow-up study. Gerodontology 22(3): 130-136
Lewis, C.E.; Woods, S.E.; Lohr, J.; Poynter, M.; Engel, A.M.; Rusche, J. 2004: Level of education and patient opinion: significant differences in perceptions of health care. Current Surgery 61(5): 504-510
Iakimenko, O.N.; Gomazkov, O.A.; Ektova, T.V.; Aparina, T.V.; Dilakian, E.A.; Britov, A.N. 2005: Level of endothelial vasodilatation and activity of angiotensin converting enzyme as criterion of efficacy of therapy in patients with mild and moderate hypertension. Kardiologiia 45(2): 15-19
Gutt, R.W. 1953: Level of erythrocytes in liver diseases. Patologia Polska 4(2): 125-143
Bossard, N.; Boissel, F.ço.-H.; Boissel, J.-P. 2004: Level of evidence and therapeutic evaluation: need for more thoughts. Fundamental and Clinical Pharmacology 18(3): 365-372
Darmoni, S.J.; Amsallem, E.; Haugh, M.; Lukacs, B.; Leroux, V.; Thirion, B.; Weber, J.; Boissel, J.P. 2003: Level of evidence as a future gold standard for the content quality of health resources on the internet. Methods of Information in Medicine 42(3): 220-225
Obremskey, W.T.; Pappas, N.; Attallah-Wasif, E.; Tornetta, P.; Bhandari, M. 2005: Level of evidence in orthopaedic journals. Journal of Bone and Joint Surgery. American Volume 87(12): 2632-2638
Proescholdt, M.A.; Macher, C.; Woertgen, C.; Brawanski, A. 2005: Level of evidence in the literature concerning brain tumor resection. Clinical Neurology and Neurosurgery 107(2): 95-98
Tosiello, L.L.; Reddy, N. 2004: Level of exercise and risk of cardiovascular disease. JAMA 291(2): 183; Author Reply 183-4
Rolla, G.; Nebiolo, F.; Guida, G.; Heffler, E.; Bommarito, L.; Bergia, R. 2006: Level of exhaled nitric oxide during human anaphylaxis. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 97(2): 264-265
Kendler, K.S.; Aggen, S.H.; Prescott, C.A.; Jacobson, K.C.; Neale, M.C. 2004: Level of family dysfunction and genetic influences on smoking in women. Psychological Medicine 34(7): 1263-1269
Sura, W.; Murphy, S.O.; Gonzales, I. 2006: Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: a pilot study. Oncology Nursing Forum 33(5): 1015-1021
Apor, P.ét. 2004: Level of fitness or physical activity as a modifying factor of cardiovascular risk. Orvosi Hetilap 145(35): 1801-1803
Bastiaannet, E.; Hoekstra, O.S.; Oyen, W.J.G.; Jager, P.L.; Wobbes, T.; Hoekstra, H.J. 2006: Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases. Annals of Surgical Oncology 13(7): 919-926
Li, K.; Li, W.; Huang, Y.-f.; Shang, X.-j. 2007: Level of free L-carnitine in human seminal plasma and its correlation with semen quality. Zhonghua Nan Ke Xue 13(2): 143-146
Tsielens, E.A.; Skarde, I.K. 1956: Level of free choline in blood serum in cancerous patients. Voprosy Kliniki i Lecheniia Zlokachestvennykh Novoobrazovanii 4: 209-214
Kubo, H.; Watari, H. 1958: Level of free energy from diphosphopyridine nucleotide combined with phosphoglyceraldehyde dehydrogenase. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 152(2): 375-377
Shepherd, J.B.; Green, K.R.; Omobien, E.O. 2005: Level of functioning and recidivism risk among adolescent offenders. Adolescence 40(157): 23-32
Benazzi, F. 2004: Level of functioning in hypomania of bipolar Ii disorder. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 49(3): 214-215
Klen, R.; Kansky, M. 1957: Level of gamma globulins after perforative keratoplasty. Ceskoslovenska Oftalmologie 13(1): 29-31
Gikas, A.; Sotiropoulos, A.; Politakis, P.; Spanou, E.; Apostolou, O.; Pappas, S. 2006: Level of glycaemic and lipid control among diabetic patients in Greek primary care. European Journal of General Practice 12(4): 181-182
Pruiksma, R. 2006: Level of hCG for considering an ectopic pregnancy. American Family Physician 73(8): 1331; Author Reply 1331
Yesil, O.F.; Yildiz, A.; Yavuz, O. 2004: Level of heavy metals in some edible and poisonous macrofungi from Batman of South East Anatolia, Turkey. Journal of Environmental Biology 25(3): 263-268
Vargues, R.; Moraud, B.; Lortholary, J. 1962: Level of hemolytic complement (C") in the serum of newborn animals. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 156: 733-737
Miroshnikov, A.I.; Masalimov, Z.K.; Bruskov, V.I. 2004: Level of hydrogen peroxide in electrochemically activated solutions and study of its effect on growth of Escherichia coli. Biofizika 49(1): 32-37
Khozinskii, V.I.; Karaseva, I.; Svezhinina, I.A.; Lysunkina, V.A. 1963: Level of immunity in recipients of live polyvaccine and poliomyelitis patients. Meditsinskii Zhurnal Uzbekistana 2: 30-36
Perunski, S.; Lang, Börn.; Pohl, Y.; Filippi, A. 2005: Level of information concerning dental injuries and their prevention in Swiss basketball--a survey among players and coaches. Dental Traumatology: Official Publication of International Association for Dental Traumatology 21(4): 195-200
Kooperstein, S.I.; Schifrin, A.; Leahy, T.J. 1962: Level of initial blood pressure and subsequent development of essential hypertension. A ten and fifteen year follow-up study. American Journal of Cardiology 10: 416-423
Gribova, I.E.; Gnedenko, B.B.; Poleshchuk, V.V.; Morozov, S.G. 2003: Level of interferon-gamma, tumor necrosis factor alpha, and antibodies to them in blood serum from Parkinson disease patients. Biomeditsinskaia Khimiia 49(2): 208-212
Charubczyk, A.; Kuna, P. 2005: Level of interleukin-12 and interferon gamma in blood serum of children with neoplasms and allergy. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(114): 761-764
Benda, R.; Morelec, R.; Guilbert 1953: Level of isoniazid in the blood following intravenous administration. Revue de la Tuberculose 17(1-2): 90-94
Sarafidis, P.A.; Bakris, G.L. 2006: Level of kidney function determines cardiovascular fate after coronary bypass graft surgery. Circulation 113(8): 1046-1047
Niedzielska, K.; Wolańczyk, T.; Baker, G.A.; Jakoby, A.; Doughty, J.; De Boer, H. 2004: Level of knowledge about epilepsy among Polish patients with epilepsy and their families in the European study SPOKE (Sanofi-Synthelabo Programme for Outcome Knowledge of Epilepsy). Neurologia i Neurochirurgia Polska 38(6): 447-455
Abellán Alemán, Jé.; Leal Hernández, M.; Martínez Pastor, A.; Hernández Menárguez, F.; García-Galbis Marín, Jé.Antonio.; Jara Gómez, Pón. 2006: Level of knowledge and action on lipaemia among Spanish primary and specialist care doctors. Press cholesterol study. Atencion Primaria 38(4): 206-211
Khan, L.A.; Khan, S.A. 2000: Level of knowledge and self-care in diabetics in a community hospital in Najran. Annals of Saudi Medicine 20(3-4): 300-301
Bin Afif, S.; Al-Mubarak, S. 2006: Level of knowledge in diabetes medical care and disease complication among Saudi diabetics. Saudi Medical Journal 27(12): 1926-1928
Muñoz-Muñiz, F.Elizabeth.; Zamorano-Echavarría, F.; Martínez-Torres, J.; Garrido-Amieva, Mía.Elena. 2006: Level of knowledge of the family physician about preventive stomatology. Revista Medica del Instituto Mexicano del Seguro Social 44(1): 83-87
Monod, H.; Saint-Saens, M.; Scherrer, J.; Soula, C. 1960: Level of lactic acid in the venous blood efferent from a working muscle in man. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 154: 21-24
Anonymous 1959: Level of life & health. Revista Medica de Chile 87(5): 385-388
Granillo, R. 1959: Level of life and hygienic indices of the Mexican Republic. La Prensa Medica Mexicana 24: 174-188
Maiat, V.S. 1953: Level of ligation of the vena saphena magna. Khirurgiia 11: 84-85
Poliiants, I.V. 2004: Level of lipid peroxides and activity of antioxidant system enzymes in pulmonary tissue of rats with acute pneumonia. Fiziolohichnyi Zhurnal 50(3): 44-46
Filimonov, P.N.; Sukhenko, T.G.; Papantonopulo, A.N.; Gavrilova, N.I.; Shkurupii, V.A. 2005: Level of liver fibrosis and immune status of mice of different age after heroin treatment and long abstinence. Bulletin of Experimental Biology and Medicine 140(6): 723-725
Szyszkowska, A.M. 2004: Level of lysozyme in saliva of patients suffering from dental infection and treated with herbal drugs. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 16(91): 44-47
Bonar, A.; Chmiela, M.; Rózalska, B. 2004: Level of mannose-binding lectin (MBL) in patients with tuberculosis. Pneumonologia i Alergologia Polska 72(5-6): 201-205
Arvy, L.; Quivy, D. 1955: Level of mast cells in the tongue and coagulability of the blood in the dog during various shocks. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149(5-6): 481-485
Seligmann, A.W.; McGRATH, N.E.; Pratt, L. 1957: Level of medical information among clinic patients. Journal of Chronic Diseases 6(5): 497-509
Wittenborn, J.R. 1950: Level of mental health as a factor in the implications of Rorschach scores. Journal of Consulting Psychology 14(6): 469-472
Amonov, I.I. 2004: Level of microelements and anemia in pregnant women living in iodine deficient endemic area. Voprosy Pitaniia 73(1): 41-44
Garibov, R.E.; Kniazeva, G.V.; Luk'ianova, S.N.; Berdiugin, V.V. 2005: Level of microelements-metals in animal blood as an informative indicator of response to low-intensity short duration electromagnetic irradiation. Radiatsionnaia Biologiia Radioecologiia 45(5): 587-591
Nisbet, J.D. 1952: Level of national intelligence. Nature 170(4333): 852
Luo, R.; Mao, M.; Xiao, X. 2001: Level of nerve growth factor protein in cerebellar cortex of rat pups in intrauterine growth retardation model by clamping the uterine vasculature of pregnant rat. Hua Xi Yi Ke da Xue Xue Bao 32(1): 89-91
Johnstone, E.; Brown, K.; Saunders, C.; Roberts, K.; Drury, M.; Walton, R.; Murphy, M. 2004: Level of nicotine replacement during a quit-smoking attempt. Nicotine and Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 6(2): 377-379
Dioguardi, N.; Magnoni, A. 1951: Level of nicotinic acid, trigonelline and trogonellinamide in duodenal juice in normal men. Rivistadi Gastro-Enterologia 3(6): 213
Artiukhov, V.F.; Gusinskaia, V.V.; Mikhileva, E.A. 2005: Level of nitric oxide and tumor necrosis factor-alpha production by human blood neutrophils under UV-irradiation. Radiatsionnaia Biologiia Radioecologiia 45(5): 576-580
Shirgoska, B.; Trajkovska, T.; Soljakova, M.; Simjanovska, L.; Isijanovska, R.; Netkovski, J.; Efremov, G.D. 2005: Level of nitric oxide in hypertensive patients scheduled on general anaesthesia. Prilozi 26(1): 13-24
Komarievtseva, I.O.; Orlova, O.A.; Blahodarenko, I.A. 2002: Level of nitric oxide in the kidneys during apoptosis activation. Ukrains'kyi Biokhimichnyi Zhurnal 74(4): 116-119
Gaworska-Krzemińska, A.; Ksiazek, J.; Grabowska, H.; Zwierzyńska, H. 2005: Level of nursing care vs life quality of patients in the terminal stage of a disease. Roczniki Akademii Medycznej W Bialymstoku 50(Suppl 1): 288-290
Mainio, A.; Hakko, Hä.; Niemelä, A.; Salo, J.; Koivukangas, J.; Räsänen, P. 2005: Level of obsessionality among neurosurgical patients with a primary brain tumor. Journal of Neuropsychiatry and Clinical Neurosciences 17(3): 399-404
Di Domizio, L.; Bono, C. 1951: Level of penicillin in blood serum in relation to renal function. Il Friuli Medico 6(1): 122-128
Dobek, M.; Rudnicka, M.; Znamierowska, M. 1956: Level of penicillin in the cerebrospinal fluid during therapy of neurosyphilis. Neurologia Neurochirurgia i Psychiatria Polska 6(3): 321-328
Clemes, S.; Tanous, J.C.; Kantor, R.E. 1963: Level of perceptual development and psychosomatic illness. Journal of Projective Techniques 27: 279-287
Latzko, E.; Gibbs, M. 1969: Level of photosynthetic intermediates in isolated spinach chloroplasts. Plant Physiology 44(3): 396-402
Canivet, J.; Poidatz, J. 1961: Level of plasma 17-hydroxycorticoids and curve of the disappearance from the plasma of cortisol injected in diabetes mellitus. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 155: 1922-1924
Ingle, D.J.; Flores, V.; Torralba, G. 1956: Level of plasma amino acids in eviscerate rats given glucose and fructose with and without insulin. Diabetes 5(1): 53-54
Lehtinen, V.; Sohlman, B.; Kovess-Masfety, V. 2005: Level of positive mental health in the European Union: results from the Eurobarometer 2002 survey. Clinical Practice and Epidemiology in Mental Health: Cp and Emh 1: 9
Lee, A.; Garner, A.; Fearnside, M.; Harrison, K. 2003: Level of prehospital care and risk of mortality in patients with and without severe blunt head injury. Injury 34(11): 815-819
Ramponi, C.; Richardson-Klavehn, A.; Gardiner, J.M. 2004: Level of processing and age affect involuntary conceptual priming of weak but not strong associates. Experimental Psychology 51(3): 159-164
Jia, E-Zhi.; Yang, Z-Jian.; Chen, S-Wei.; Qi, G-Yao.; You, C-Fa.; Ma, J-Feng.; Zhang, J-Xin.; Wang, Z-Zhen.; Qian, W-Chong.; Wang, H-Yan.; Ma, W-Zhu. 2005: Level of proinsulin in association with cardiovascular risk factors and sleep snoring. World Journal of Gastroenterology 11(32): 5047-5052
Dzialoszynski, L.; Kotik, T. 1959: Level of proteins and protein fractions in the blood serum of calves in relation to age. Acta Physiologica Polonica 10: 374-383
Fel'dmann, M.G. 1954: Level of prothrombia in blood plasma in acute dysentery in children. Pediatriia 2: 41-45
Lysakov, N.A. 1959: Level of radiations in aircraft repair shops and in aircraft cabins. Voenno-Meditsinskii Zhurnal 8(4): 75
Sinnamon, K.T.; Courtney, A.E.; Maxwell, A.P.; McNamee, P.T.; Savage, G.; Fogarty, D.G. 2007: Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(7): 1969-1973
Sheffield, F.D.; Jenkins, W.O. 1952: Level of repetition in the spread of effect. Journal of Experimental Psychology 44(2): 101-107
Pérez-Padilla, A.; Pellón, R. 2006: Level of response suppression and amphetamine effects on negatively punished adjunctive licking. Behavioural Pharmacology 17(1): 43-49
Tapert, S.F.; Pulido, C.; Paulus, M.P.; Schuckit, M.A.; Burke, C. 2004: Level of response to alcohol and brain response during visual working memory. Journal of Studies on Alcohol 65(6): 692-700
Mahovic, D.; Petravic, D.; Petelin, Z.; Zurak, N.; Horvat, G.; Hajnsek, S. 2004: Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis. Clinical Neurology and Neurosurgery 106(3): 230-232
Crocker, J.; Luhtanen, R.K. 2003: Level of self-esteem and contingencies of self-worth: unique effects on academic, social, and financial problems in college students. Personality and Social Psychology Bulletin 29(6): 701-712
Rosenbaum, M.E.; Horne, W.C.; Chalmers, D.K. 1962: Level of self-esteem and the learning of imitation and nonimitation. Journal of Personality 30: 147-156
Balik, J.; Fabryova, D. 1963: Level of serum cholesterol and phospholipids in patients with xanthelasma. Ceskoslovenska Oftalmologie 19: 86-89
Czajka-Kropaczek, L. 1961: Level of serum mucoproteins during the course of pulmonary and meningeal tuberculosis. Gruzlica 29: 857-864
Alekperov, R.T.; Timchenko, A.V.; Samsonov, M.I.; Guseva, N.G.; Nasonov, E.L. 2004: Level of soluble tumor necrosis factor receptor type i in patients with systemic scleroderma. Terapevticheskii Arkhiv 76(5): 11-15
Reese, H.W. 1961: Level of stimulus pretraining and paired-associate learning. Child Development 32: 89-93
Suominen, K.; Isometsä, E.; Ostamo, A.; Lönnqvist, J. 2004: Level of suicidal intent predicts overall mortality and suicide after attempted suicide: a 12-year follow-up study. Bmc Psychiatry 4: 11
Kawato, H.; Hitosugi, M.; Nagai, T.; Tokudome, S. 2004: Level of supervision of young children while in bathtubs. Ambulatory pediatrics: the official journal of the Ambulatory Pediatric Association 4(6): 521; author reply 521
Muszyńska-Rosłan, K.; Krawczuk-Rybak, M.; Protas, P.T.; Hołownia, A. 2006: Level of tau protein in children treated for acute lymphoblastic leukemia. Pediatric Neurology 34(5): 367-371
Mauvoisin, F. 1951: Level of the pelvis. Revuedu Rhumatisme et des Maladies Osteo-Articulaires 18(10): 555
Zhang, J.-x.; Sun, G.-y.; Chen, Y.-l.; Wang, P.-x.; Yuan, Z.-m.; Zhou, Y.-l. 2004: Level of tissue plasminogen activator protein in pulmonary artery in acute pulmonary thromboembolism in rabbit. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16(8): 481-483
Michoń, P. 2002: Level of total and ionized magnesium fraction based on biochemical analysis of blood and hair and effect of supplemented magnesium (Slow Mag B6) on selected parameters in hypertension of patients treated with various groups of drugs. Annales Academiae Medicae Stetinensis 48: 85-97
Blecha, J.; Pazderka, J.; Frank, M. 1963: Level of total esterified fatty acids in the skin surface in the 1st year of life. Ceskoslovenska Pediatrie 18: 97-103
Atanasijević, T.; Nikolić, S.; Djokić, V. 2004: Level of total injury severity as a possible parameter for evaluation of height in fatal falls. Srpski Arhiv Za Celokupno Lekarstvo 132(3-4): 96-98
Klimek, R.; Wiszniewska, E.; Zamello, J. 1959: Level of transaminase in the blood in obstetric cases. Ginekologia Polska 30: 345-350
Bunyaratavej, N.; Soontrapa, S.; Rojanasthin, S.; Kitimanon, N.; Lektrakul, S. 2005: Level of undercarboxylated osteocalcin in reproductive Thai females. Journal of the Medical Association of Thailand 88(Suppl 5): S37-S39
De Felipe Medina, R. 2003: Level of understanding of patients on anticoagulants at a health centre: relationship of this and monitoring of therapy. Atencion Primaria 32(2): 101-105
Del Castillo, E.B.; Argonz, J. 1953: Level of urinary sediment; utilization in determination of estrogenic activity. Acta Physiologica Latino Americana 3(2-3): 85-88
Ferraris, G. 1953: Level of urinary steroids of hormonal origin in fibromatosis. Minerva Ginecologica 5(7): 276-280
Shang, T.; Cheng, Z.-x.; Jin, F.; Zhang, L. 2006: Level of urocortin mRNA during labor and effect of urocortin on myometrial contractility in vitro. Zhonghua Fu Chan Ke Za Zhi 41(4): 249-252
Liu, J.; Wang, Q.; Chen, Y.-h.; Qin, G.-l.; Zhao, J.-h.; Zhu, L.-c. 2005: Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity. Zhonghua Er Ke Za Zhi 43(12): 908-910
Abramov, S.A.; Kotenko, S.T.; Ramazanov, A.S.; Islamova, F.I. 2003: Level of vitamins B in yeasts of the Saccharomyces species depending on the composition of culture media. Prikladnaia Biokhimiia i Mikrobiologiia 39(4): 438-440
Cinar, U.; Yigit, O.; Vural, C.; Alkan, S.; Kayaoglu, S.; Dadas, B. 2003: Level of vocal folds as projected on the exterior thyroid cartilage. Laryngoscope 113(10): 1813-1816
Prokhorova, N.T. 1956: Level of volatile acids in rye bread as an indicator of its acidity. Voprosy Pitaniia 15(3): 26-30
Gruenewald, G.; Zuberbier, E. 1960: Level registration as a method of psychomotor research on speech. Archiv für Psychiatrie und Nervenkrankheiten Vereinigt Mit Zeitschrift für die Gesamte Neurologie und Psychiatrie 200: 427-438
Mukherjee, D.P.; Ray, N.; Acton, S.T. 2004: Level set analysis for leukocyte detection and tracking. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 13(4): 562-572
Chen, Q.; Zhou, Z.M.; Qu, Y.G.; Heng, P.A.; Xia, D.S. 2004: Level set based auto segmentation of the tagged left ventricle MR images. Studies in Health Technology and Informatics 98: 63-65
Manniesing, R.; Velthuis, B.K.; van Leeuwen, M.S.; van der Schaaf, I.C.; van Laar, P.J.; Niessen, W.J. 2006: Level set based cerebral vasculature segmentation and diameter quantification in CT angiography. Medical Image Analysis 10(2): 200-214
Huang, Y.-L.; Jiang, Y.-R.; Chen, D.-R.; Moon, W.K. 2007: Level set contouring for breast tumor in sonography. Journal of Digital Imaging 20(3): 238-247
Brox, T.; Weickert, J. 2006: Level set segmentation with multiple regions. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 15(10): 3213-3218
Lee, S.-H.; Seo, J.K. 2006: Level set-based bimodal segmentation with stationary global minimum. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 15(9): 2843-2852
Watanabe, M.; Kikinis, R.; Westin, C-Fredrik. 2003: Level set-based integration of segmentation and computational fluid dynamics for flow correction in phase contrast angiography. Academic Radiology 10(12): 1416-1423
Makino, H.; Tasaki, S. 2003: Level spacing statistics of classically integrable systems: investigation along the lines of the Berry-Robnik approach. Physical Review. E Statistical Nonlinear and Soft Matter Physics 67(6 Part 2): 066205
Otsuka, H.; Mori, K.; Okabe, Y.; Nomura, K. 2005: Level spectroscopy of the square-lattice three-state Potts model with a ferromagnetic next-nearest-neighbor coupling. Physical Review. E Statistical Nonlinear and Soft Matter Physics 72(4 Part 2): 046103
Hlushchuk, Y.; Russ, S. 2003: Level statistics and eigenfunctions of pseudointegrable systems: dependence on energy and genus number. Physical Review. E Statistical Nonlinear and Soft Matter Physics 68(1 Part 2): 016203
Seweryniak, D.; Woods, P.J.; Carpenter, M.P.; Davinson, T.; Janssens, R.V.F.; Jenkins, D.G.; Lauritsen, T.; Lister, C.J.; Ruiz, C.; Shergur, J.; Sinha, S.; Woehr, A. 2005: Level structure of 22Mg: implications for the 21Na(p,gamma)22Mg astrophysical reaction rate and for the 22Mg Mass. Physical Review Letters 94(3): 032501
Steiner, D.; Aharoni, A.; Banin, U.; Millo, O. 2006: Level structure of InAs quantum dots in two-dimensional assemblies. Nano Letters 6(10): 2201-2205
Mohr, W.K.; Pumariega, A.J. 2004: Level systems: inpatient programming whose time has passed. Journal of Child and Adolescent Psychiatric Nursing: Official Publication of the Association of Child and Adolescent Psychiatric Nurses Inc 17(3): 113-125
Mukhin, V.V.; Perederiĭ, G.S.; Kharkovenko, N.M. 2003: Level, structure and dynamics of combined forms of occupational diseases among coal miners of Donetsk region. Meditsina Truda i Promyshlennaia Ekologiia 9: 11-13
Archdeacon, M.T.; Stern, P.J. 2006: Level-i orthopaedic trauma care: a model for longevity. Journal of Bone and Joint Surgery. American Volume 88(10): 2305-2309
Waller, T.A. 2007: Level-Ii vs. level-IIi visits: cracking the codes. Family Practice Management 14(1): 21-25
Fao, T. 2006: Level-IV visits. Family Practice Management 13(4): 23; Author Reply 23; Discussion 25
Devin, C.; Chong, P.Y.; Holt, G.E.; Feurer, I.; Gonzalez, A.; Merchant, N.; Schwartz, H.S. 2006: Level-adjusted perioperative risk of sacral amputations. Journal of Surgical Oncology 94(3): 203-211
Edwards, P.J..; Hurst, R.B.. 2001: Level-crossing statistics of the horizontal wind speed in the planetary surface boundary layer. Chaos 11(3): 611-618
Cohen, L.D. 1954: Level-of-aspiration behavior and feelings of adequacy and self-acceptance. Journal of Abnormal Psychology 49(1): 84-86
Sowers, W.; Pumariega, A.; Huffine, C.; Fallon, T. 2003: Level-of-care decision making in behavioral health services: the LOCUS and the CALOCUS. Psychiatric Services 54(11): 1461-1463
Nicoladis, E.; Murphy, V.A. 2004: Level-ordering does not constrain children's ungrammatical compounds. Brain and Language 90(1-3): 487-494
Van Bemmel, C.M.; Spreeuwers, L.J.; Viergever, M.A.; Niessen, W.J. 2003: Level-set-based artery-vein separation in blood pool agent CE-MR angiograms. IEEE Transactions on Medical Imaging 22(10): 1224-1234
Merino, J.M. 2001: Multiple pulmonary metastasis and exacerbation of dyspnea. Revista de Medicina de la Universidad de Navarra 47(3): 43-44
Sander, C.; Sander, F.M.; Sander, F.G.ün. 2006: Leveling of the second molar with a superelastic spring. Journal of Orofacial Orthopedics 67(3): 186-195
Platt, L.D. 1991: Leveling out. Ultrasound in Obstetrics and Gynecology: the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 1(2): 83-84
Frahm, J.L.; Muddiman, D.C.; Burke, M.J. 2005: Leveling response factors in the electrospray ionization process using a heated capillary interface. Journal of the American Society for Mass Spectrometry 16(5): 772-778
Berkowitz, L. 1957: Leveling tendencies and the complexity-simplicity dimension. Journal of Personality 25(6): 743-751
Bernstein, R.L.; Preston, C.B.; Lampasso, J. 2007: Leveling the curve of Spee with a continuous archwire technique: a long term cephalometric study. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 131(3): 363-371
Freeman, L. 2003: Leveling the field: answers to frequently asked questions about the Cartagena Biosafety Protocol. Genewatch: a Bulletin of the Committee for Responsible Genetics 16(6): 12-14
Jerger, J. 2003: Leveling the high-frequency playing field. Journal of the American Academy of Audiology 14(8): 1 P Following Table of Contents
Medkova, I.L.; Ieromuzo, A.A.; Ivanov, A.N.; Mosiakina, L.I.; Biriukova, L.S. 2004: Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet. Klinicheskaia Meditsina 82(6): 58-60
Lublin, M.; Lyass, S.; Lahmann, B.; Cunneen, S.A.; Khalili, T.M.; Elashoff, J.D.; Phillips, E.H. 2005: Leveling the learning curve for laparoscopic bariatric surgery. Surgical Endoscopy 19(6): 845-848
Shinkman, R. 2003: Leveling the paying field: can malpractice be made fair? Pennsylvania study examines various reforms. Healthcare Leadership and Management Report 11(6): 10; 12
Mirel, L.H. 2006: Leveling the play field: providing equal access to health insurance to all District of Columbia residents and workers. Managed care interface 19(2): 49-51
Meghani, S.H. 2005: Leveling the playing field: does pain disparity literature suffer from a reporting bias?. Pain Medicine 6(3): 269-70; Author Reply 271-2
Doyle, R. 2005: Leveling the playing field: economic development helps women pull even with men. Scientific American 292(6): 32
Michel, L.G. 2003: Leveling the playing field: nurses' rights in state board disciplinary actions. Kansas Nurse 78(1): 1-2
Sullivan, L.W.; Eagel, B.A. 2005: Leveling the playing field: recognizing and rectifying disparities in management of pain. Pain Medicine 6(1): 5-10
Leech, L.L.; Holcomb, J.M. 2004: Leveling the playing field: the development of a distance education program in rehabilitation counseling. Assistive Technology: the Official Journal of Resna 16(2): 135-143
Holzman, P.S.; Gardner, R.W. 1960: Leveling-sharpening and memory organization. Journal of Abnormal and Social Psychology 61: 176-180
Gardner, R.W.; Lohrenz, L.J. 1960: Leveling-sharpening and serial reproduction of a story. Bulletin of the Menninger Clinic 24: 295-304
Cloutier-Fisher, D.; Skinner, M.W. 2006: Levelling the playing field? Exploring the implications of managed competition for voluntary sector providers of long-term care in small town Ontario. Health and Place 12(1): 97-109
Roff, M. 2003: Levelling the playing fields of England: promoting health in deprived communities. Journal of the Royal Society for the Promotion of Health 123(1): 20-22
Caccia Perugini, I.; Deleo, T.; Foti, L.; Orru, A. 1964: Levels and Composition of Neutral Lipids in the Liver of Normal Rat. La Ricerca Scientifica. 2. Ser.(Part 2): Rendiconti. Sezione B: Biologica 5: 551-562
Caccia Perugini, I.; Delio, T.; Foti, L.; Orru, A. 1964: Levels and Composition of Phospholipids in the Liver of Normal Rat. La Ricerca Scientifica. 2. Ser.(Part 2): Rendiconti. Sezione B: Biologica 5: 563-574
Anderson, D.O.; Ferris, B.G.; Zickmantel, R. 1964: Levels of Air Pollution and Respiratory Disease in Berlin, New Hampshire. American Review of Respiratory Disease 90: 877-887
Swanson, A.B. 1964: Levels of Amputation of Fingers and Hand--Considerations for Treatment. Surgical Clinics of North America 44: 1115-1126
Fleischer, E. 1965: Levels of Aspiration and Vocational Choice in the Cerebral Palsied Client. Rehabilitation Literature 26: 9-11
Mascarenhasrdos, S. 1963: Levels of Authority--Central, Regional and Local--In Public Health Programs in Brazil. Arquivos da Faculdade de Higiene e Saude Publica da Universidade de Sao Paulo 17: 223-240
Vancauwenberge, H.; Lefebvre, P.; Palem-Vliers, M. 1963: Levels of Blood and Urinary Corticosteroids in Arterial Hypertension. La Presse Medicale 71: 2291-2294
Hibbitt, K.G. 1964: Levels of Coenzyme a in the Liver of Normal Cows and of Cows Suffering from Primary Ketosis. Nature 204: 206
Bartova, A.; Mikulaj, L. 1965: Levels of Free and Bound 17-Hydroxycorticosteroids in the Human Plasma. Bratislavske Lekarske Listy 45: 547-553
Voloir, P. 1964: Levels of Functional Amputation of the Thumb and Fingers. Concours Medical 86: 5561-5571
Sato, T.; Greenblatt, R.B.; Mahesh, V.B. 1965: Levels of Luteinizing Hormone during the Menstrual Cycle determined by Immunologic Technics. Fertility and Sterility 16: 223-228
Luyken, R. 1964: Levels of Nutrition in the Cassava Areas of Java. Voeding 25: 99-104
Klein, J. 1965: Levels of Perceptual Organization and of Performance after time for Reflection. British Journal of Educational Psychology 35: 60-62
Judson, A.J.; Katahn, M. 1964: Levels of Personality Organization and Production of Associative Sequences in Process-Reactive Schizophrenia. Journal of Consulting Psychology 28: 208-213
Seibel, R. 1964: Levels of Practice, Learning Curves, and System Values for Human Performance on Complex Tasks. Human Factors 6: 293-298
Alfonso, G. 1963: Levels of Rifamycin Sv in the Aqueous Humor and its Tolerance after Subconjunctival Administration in the Rabbit. Chemotherapia 10: 577-585
Kaczynski, M.; Bernaskiewicz, E.; Wypych, M.; Wojnicka, H. 1964: Levels of Sialic Acid, Cholinesterase and some Electrolytes in Treated Early Schizophrenia. Polski Tygodnik Lekarski 19: 1074-1075
Määttä, M.; Tervahartiala, T.; Vesti, E.; Airaksinen, J.; Sorsa, T. 2006: Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. Journal of Glaucoma 15(3): 229-237
Oh, J-Eun.; Chang, Y-Seok.; Ikonomou, M.G. 2002: Levels and characteristic homologue patterns of polychlorinated dibenzo-p-dioxins and dibenzofurans in various incinerator emissions and in air collected near an incinerator. Journal of the Air and Waste Management Association 52(1): 69-75
Yuan, B.-j.; Liu, Z.-z.; Ding, X.-r.; Zou, J.-m. 2006: Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 24(2): 96-98
Amakura, Y.; Tsutsumi, T.; Sasaki, K.; Maitani, T. 2003: Levels and congener distributions of PCDDs, PCDFs and Co-PCBs in Japanese retail fresh and frozen vegetables. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 44(6): 294-302
Henriksen, E.O.; Gabrielsen, G.W.; Skaare, J.U. 1996: Levels and congener pattern of polychlorinated biphenyls in kittiwakes (Rissa tridactyla), in relation to mobilization of body-lipids associated with reproduction. Environmental Pollution 92(1): 27-37
Mier, N.; Ory, M.G.; Zhan, D.; Wang, S.; Burdine, J.N. 2007: Levels and correlates of exercise in a border mexican american population. American Journal of Health Behavior 31(2): 159-169
Giovannangelo, M.ël.E.C.A.; Gehring, U.; Nordling, E.; Oldenwening, M.; van Rijswijk, K.; de Wind, S.; Hoek, G.; Heinrich, J.; Bellander, T.; Brunekreef, B. 2007: Levels and determinants of beta(1-->3)-glucans and fungal extracellular polysaccharides in house dust of (pre-)school children in three European countries. Environment International 33(1): 9-16
Zhang, J.; Chen, Q.; Wang, N.; Zhang, J. 2003: Levels and distribution of 15 rare earth elements in tumor and normal lung tissue from the patients with lung cancer. Wei Sheng Yan Jiu 32(5): 423-426
Bodell, W.J.; Bodell, A.P.; Giannini, D.D. 2007: Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol). Neuro-Oncology 9(1): 12-19
Wallon, H. 1956: Levels and fluctuations of the ego. L' Evolution Psychiatrique 1: 389-401
Norheim, G. 1987: Levels and interactions of heavy metals in sea birds from Svalbard and the Antarctic. Environmental Pollution 47(2): 83-94
Chen, J.; Yu, Y.-p.; Huang, X.-l.; Chen, F.-b. 2003: Levels and mRNA expression of interleukin-8 in gastric and duodenal mucosa of children Infected with Helicobacter pylori. Zhonghua Er Ke Za Zhi 41(3): 168-171
Godunov, S.F.; Novoselova, A.I. 1955: Levels and methods of amputation in necrosis of extremities in endarteritis obliterans. Vestnik Khirurgii Imeni I. I. Grekova 76(11): 38-45
Kotov, A.P. 1955: Levels and methods of amputation in spontaneous gangrene. Ortopediia Travmatologiia i Protezirovanie 1: 33-37
Gehring, U.; Bischof, W.; Borte, M.; Herbarth, O.; Wichmann, H.-E.; Heinrich, J. 2004: Levels and predictors of endotoxin in mattress dust samples from East and West German homes. Indoor Air 14(4): 284-292
Greenberger, C.; Reches, H.; Riba, S. 2006: Levels and predictors of knowledge and attitudes regarding pain among Israeli baccalaureate nursing students and nurses pursuing specialty certification. International Journal of Nursing Education Scholarship 3: Article 8
Kambarami, R.A. 2002: Levels and risk factors for mortality in infants with birth weights between 500 and 1,800 grams in a developing country: a hospital based study. Central African Journal of Medicine 48(11-12): 133-136
Ondimu, K.N. 2000: Levels and risk factors of operative deliveries in four health facilities in Kisumu District, Kenya. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 20(5): 486-491
Krest'iashin, S.I. 1962: Levels and spectra of traffic noise penetrating into living quarters. Gigiena i Sanitariia 27: 94-98
Kopylov, F.A. 1959: Levels and technics of amputation. Ortopediia Travmatologiia i Protezirovanie 20(5): 73-76
Lebeuf, M.; Gouteux, B.; Measures, L.; Trottier, S. 2004: Levels and temporal trends (1988-1999) of polybrominated diphenyl ethers in beluga whales (Delphinapterus leucas) from the St. Lawrence Estuary, Canada. Environmental Science and Technology 38(11): 2971-2977
Stanton, C.K.; Holtz, S.A. 2006: Levels and trends in cesarean birth in the developing world. Studies in Family Planning 37(1): 41-48
Nhacolo, A.Q.; Nhalungo, D.A.; Sacoor, C.N.; Aponte, J.J.; Thompson, R.; Alonso, P. 2006: Levels and trends of demographic indices in southern rural Mozambique: evidence from demographic surveillance in Manhiça district. Bmc Public Health 6: 291
Chiu, C.-A.; Wu, C.-J.; Yang, C.-H.; Fang, C.-Y.; Hsieh, Y.-K.; Hang, C.-L.; Hung, W.-C.; Chen, C.-J.; Chen, S.-M.; Yu, T.-H.; Yeh, K.-H.; Fu, M.; Yip, H.-K. 2005: Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain. Chang Gung Medical Journal 28(10): 699-707
Torres-Lapasió, J.R.; García-Alvarez-Coque, M.C. 2006: Levels in the interpretive optimisation of selectivity in high-performance liquid chromatography: a magical mystery tour. Journal of Chromatography. a 1120(1-2): 308-321
Menghi, P.; Grasso, E.; Rizzo, A.C.; Pizzini, A.M. 1962: Levels of (total, free and conjugated) serum bilirubin in the normal newborn during the 1st week of life and their modification by prednisone treatment. Minerva Pediatrica 14: 1061-1069
Huang, W.; Caudill, S.P.; Grainger, J.; Needham, L.L.; Patterson, D.G. 2006: Levels of 1-hydroxypyrene and other monohydroxy polycyclic aromatic hydrocarbons in children: a study based on U.S. reference range values. Toxicology Letters 163(1): 10-19
Puhakainen, M.; Heikkinen, T.; Rahola, T. 2003: Levels of 90Sr and 137Cs in the urine of Finnish people. Radiation Protection Dosimetry 103(3): 255-262
Mackay, I.R.; Groom, J.; Mackay, C.R. 2002: Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes. Autoimmunity 35(8): 551-553
Araghi-Niknam, M.; Fatemi, S.H. 2003: Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cellular and Molecular Neurobiology 23(6): 945-952
Harris, M.J.; Dugger, W.M. 1986: Levels of Free and Conjugated Abscisic Acid in Developing Floral Organs of the Navel Orange (Citrus sinensi [L.] Osbeck cv Washington). Plant Physiology 82(4): 1164-1166
López de Jesús, M.; Zalduegui, A.; Ruiz de Azúa, I.ñi.; Callado, L.F.; Meana, J.J.; Sallés, J. 2006: Levels of G-protein alpha q/11 subunits and of phospholipase C-beta(1-4), -gamma, and -delta1 isoforms in postmortem human brain caudate and cortical membranes: potential functional implications. Neurochemistry International 49(1): 72-79
Lapiński, T.W.; Kovalczuk, O.; Flisiak, R.; Pancewicz, J. 2006: Levels of HBV-DNA, sFas and sFasL among healthy HBsAg carriers in period of three years. Advances in Medical Sciences 51: 46-50
Roy, D.; Sarkar, S.; Felty, Q. 2006: Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Frontiers in Bioscience: a Journal and Virtual Library 11: 889-898
Sun, D.-Q.; Zhang, Q.-Y.; Dong, Z.-Y.; Bai, F. 2006: Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with Henoch-Schonlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 8(4): 307-310
Hamzaoui, K.; Hamzaoui, A.; Ghorbel, I.; Khanfir, M.; Houman, H. 2006: Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease. Scandinavian Journal of Immunology 64(6): 655-660
Ugwoke, S.C.; Eseadi, C.; Onuigbo, L.N.; Aye, E.N.; Akaneme, I.N.; Oboegbulem, A.I.; Ezenwaji, I.O.; Nwobi, A.U.; Nwaubani, O.O.; Ezegbe, B.N.; Ede, M.O.; Orji, C.T.; Onuoha, J.C.; Onu, E.A.; Okeke, F.; Agu, P.; Omeje, J.C.; Omeke, F.; Ugwu, R.; Arumede, F.; Eneh, A. 2018: A rational-emotive stress management intervention for reducing job burnout and dysfunctional distress among special education teachers: An effect study. Medicine 97(17): E0475
Maccarrone, M.; Fezza, F.; Finazzi-Agrò, A. 2004: Levels of N-acylethanolamines in human tumors: in search of reliable data. Lipids 39(2): 193-194
Otani, T.; Yamaguchi, K.; Scherl, E.; Du, B.; Tai, H.-H.; Greifer, M.; Petrovic, L.; Daikoku, T.; Dey, S.K.; Subbaramaiah, K.; Dannenberg, A.J. 2006: Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. American Journal of Physiology. Gastrointestinal and Liver Physiology 290(2): G361-G368
Hovander, L.; Linderholm, L.; Athanasiadou, M.; Athanassiadis, I.; Bignert, A.; Fängström, B.; Kocan, A.; Petrik, J.; Trnovec, T.; Bergman, A. 2006: Levels of PCBs and their metabolites in the serum of residents of a highly contaminated area in eastern Slovakia. Environmental Science and Technology 40(12): 3696-3703
Nishijima, Y.; Yamaguchi, M.; Kojima, T.; Aihara, N.; Nakajima, R.; Kasai, K. 2006: Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthodontics and Craniofacial Research 9(2): 63-70
Wright, H.J.; Chapple, I.L.C.; Matthews, J.B. 2003: Levels of TGFbeta1 in gingival crevicular fluid during a 21-day experimental model of gingivitis. Oral Diseases 9(2): 88-94
Gallagher, P.; Mulvany, F. 2004: Levels of ability and functioning: using the WHODAS II in an Irish context. Disability and Rehabilitation 26(9): 506-517
Badt, M.I. 1958: Levels of abstraction in vocabulary definitions of mentally retarded school children. American Journal of Mental Deficiency 63(2): 241-246
Pace, F.C. 1957: Levels of accepted radiation exposure for a war emergency. Canadian Medical Association Journal 76(5): 402-404
Chistiakova, G.N.; Gazieva, I.A.; Remizova, I.I. 2006: Levels of acute phase proteins in normal pregnancy. Klinicheskaia Laboratornaia Diagnostika 4: 20-22
Elkind, M.S.V.; Coates, K.; Tai, W.; Paik, M.C.; Boden-Albala, B.; Sacco, R.L. 2006: Levels of acute phase proteins remain stable after ischemic stroke. Bmc Neurology 6: 37
Fialová, L.; Kalousová, M.; Soukupová, J.; Malbohan, I.; Krofta, L.; Mikulíková, L.; Horejsová, H.; Stípek, S.; Zima, T. 2003: Levels of advanced oxidation protein products (AOPP) in the first trimester of pregnancy. Sbornik Lekarsky 104(1): 95-102
Real, P.G.; Dreyfus, L.R. 1985: Levels of aggregation: Relative time allocation in concurrent-schedule performance. Journal of the Experimental Analysis of Behavior 43(1): 97-113
Gijzen, M.; González, R.; Barber, D.; Polo, F. 2003: Levels of airborne Gly m 1 in regions of soybean cultivation. Journal of Allergy and Clinical Immunology 112(4): 803-805
Mizejewski, G.J. 2003: Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstetrical and Gynecological Survey 58(12): 804-826
Chiba-Falek, O.; Lopez, G.J.; Nussbaum, R.L. 2006: Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Movement Disorders: Official Journal of the Movement Disorder Society 21(10): 1703-1708
Vila, Nás.; Millán, Mónica.; Ferrer, X.; Riutort, N.; Escudero, D. 2003: Levels of alpha1-antitrypsin in plasma and risk of spontaneous cervical artery dissections: a case-control study. Stroke 34(9): E168-E169
Khramov, V.A.; Prigoda, E.V. 2002: Levels of amino group nitrogen and imidazole compounds in human oral fluid. Stomatologiia 81(6): 10-11
Russell, I.F. 1995: Levels of anaesthesia and intraoperative pain at caesarean section under regional block. International Journal of Obstetric Anesthesia 4(2): 71-77
Messick, D.M.; Liebrand, W.B. 1997: Levels of analysis and the explanation of the costs and benefits of cooperation. Personality and Social Psychology Review: An Official Journal of the Society for Personality and Social Psychology Inc 1(2): 129-139
Di Piero, G. 1957: Levels of anti-A & anti-B hemagglutinins in maternal serum after pregnancy with ABO compatibility & incompatibility; report on 400 cases. Rivista di Clinica Pediatrica 59(5): 420-427
Von Dadelszen, P.; Magee, L.A.; Krajden, M.; Alasaly, K.; Popovska, V.; Devarakonda, R.M.; Money, D.M.; Patrick, D.M.; Brunham, R.C. 2003: Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. Bjog: An International Journal of Obstetrics and Gynaecology 110(8): 725-730
Blaskovic, D.; Rathova, V. 1956: Levels of antibodies against influenza viruses A, A1, B, C, and Shopeiowa 15 antibody titers in the population of Czechoslovakia. Ceskoslovenska Epidemiologie Mikrobiologie Imunologie 5(3): 113-124
Shende, N.; Gupta, S.; Kumar, S.; Harinath, B.C. 2004: Levels of antibody, free antigen and immune-complexed antigen by ELISA in different grades of sputum positive patients of pulmonary tuberculosis. Indian Journal of Pathology and Microbiology 47(3): 438-440
Latalska, M.łg.; Gerkowicz, M.; Pietraś-Trzpiel, M.łg.; Kozioł-Montewka, M.; Kosior-Jarecka, E. 2004: Levels of antiphospholipid antibodies in the serum and aqueous humor of glaucoma patients. Klinika Oczna 106(3 Suppl): 419-420
Van Wijk, C.H. 2002: Levels of anxiety and hostility in South African Navy divers. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 29(4): 271-278
Silvestri, V.; Nerini, L.; Missio, G.; Masini, M.; Faggi, S.; Gori, A.; Panella, M. 2004: Levels of anxiety and pain during chemotherapy with peripheral versus central vascular access: an experimental evaluation. Journal of Vascular Access 5(4): 147-153
Táborský, L.; Adam, P.; Sobek, O.; Dostál, M.; Dvoráková, J.; Dubská, L. 2003: Levels of apolipoprotein A-Ii in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis. Folia Microbiologica 48(6): 849-855
Fernández, V.; Morales, L.M.; Molero-Conejo, E.; Casanova, A.; Campos, G.; Raleigh, X.; Gómez, M.E.; Ryder, E. 2004: Levels of apoproteins B, A1 and CIIi as markers for cardiovascular risk in lean and obese adolescents. Investigacion Clinica 45(1): 29-42
Guo, X.; Liu, Z.; Huang, C.; You, L. 2006: Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia. Journal of Health Population and Nutrition 24(2): 214-220
Cesco, R.d.T.; Ito, I.Y.; de Albuquerque, R.F. 2003: Levels of aspartate aminotransferase (AST) in saliva of patients with different periodontal conditions. Journal of Clinical Periodontology 30(8): 752-755
Hu, B.; Chen, Y.-L.; Li, L.-H.; Hu, H.-Z. 2006: Levels of atrial natriuretic peptide in umbilical cord blood of high risk neonates. Zhongguo Dang Dai Er Ke Za Zhi 8(2): 118-120
Filmer-Bennett, G.; Klopfer, W.G. 1962: Levels of awareness in projective tests. Journal of Projective Techniques 26: 34-35
Rosenzweig, S. 1950: Levels of behavior in psychodiagnosis with special reference to the picture-frustration study. American Journal of Orthopsychiatry 20(1): 63-72
Denson, K.W. 1961: Levels of blood-coagulation factors during anticoagulant therapy with phenindione. British Medical Journal 1(5234): 1205-1210
Avrunin, A.S.; Tikhilov, R.M.; Abolin, A.B.; Shcherbak, I.G. 2005: Levels of bone mineral matrix organization and the mechanisms determining parameters of its formation. Morfologiia 127(2): 78-82
Mir, T.S.; Falkenberg, J.; Friedrich, B.; Gottschalk, U.; Lê, T.P.; Laer, S.; Weil, J. 2005: Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiology in the Young 15(4): 396-401
Karlsson, M.; Ericson, I.; van Bavel, B.; Jensen, J.-K.; Dam, M. 2006: Levels of brominated flame retardants in Northern Fulmar (Fulmarus glacialis) eggs from the Faroe Islands. Science of the Total Environment 367(2-3): 840-846
Daragó, A.; Sapota, A.; Duda-Szymańska, J. 2003: Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer. Roczniki Panstwowego Zakladu Higieny 54 Suppl: 39-40
Biezanski, W.; Bartosiewicz, W. 1961: Levels of calcium, phosphorus and basic phosphatase in the blood serum of orthopedic patients treated with ossopan. Chirurgia Narzadow Ruchu i Ortopedia Polska 26: 353-363
Anonymous 2018: A rational-emotive stress management intervention for reducing job burnout and dysfunctional distress among special education teachers: An effect study: Erratum. Medicine 97(20): E10827
Soler Palacín, P.; Monfort Gil, R.; Castells Vilella, L.; Pagone Tangorra, F.; Serres i Créixams, X.; Balcells Ramírez, J. 2004: Group B Streptococcus late-onset disease presenting as cellulitis-adenitis syndrome. Anales de Pediatria 60(1): 75-79
Cook, D.; Rocker, G.; Marshall, J.; Griffith, L.; McDonald, E.; Guyatt, G. 2006: Levels of care in the intensive care unit: a research program. American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 15(3): 269-279
Vemuri, P.; Harris, K.E.; Suh, L.A.; Grammer, L.C. 2004: Preparation of benzylpenicilloyl-polylysine: a preliminary study. Allergy and Asthma Proceedings 25(3): 165-168
Gillett, M.P.; Obineche, E.N.; Lakhani, M.S.; Abdulle, A.M.; Amirlak, I.; Al Rukhaimi, M.; Suleiman, M.N. 2001: Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure. Annals of Saudi Medicine 21(5-6): 283-286
Koang, N.K.; Ou, K.I.; Wang, T.I.; Tch'en, K.L.; Hiu, M.I. 1951: Levels of circulating eosinophils and their use as an index of prognosis in surgical shock. Chinese Medical Journal 69(9-10): 369-388
Malay, D.S. 2007: Levels of clinical evidence. Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 46(2): 63-64
Gazdik, F.; Gvozdjakova, A.; Horvathova, M.; Weissova, S.; Kucharska, J.; Pijak, M.R.; Gazdikova, K. 2002: Levels of coenzyme Q10 in asthmatics. Bratislavske Lekarske Listy 103(10): 353-356
Berblinger, K.W.; Greenhill, M.H. 1954: Levels of communication in ulcerative colitis; a case study. Psychosomatic Medicine 16(2): 156-162
Cambi, A.; Figdor, C.G. 2005: Levels of complexity in pathogen recognition by C-type lectins. Current Opinion in Immunology 17(4): 345-351
Morin, A. 2006: Levels of consciousness and self-awareness: a comparison and integration of various neurocognitive views. Consciousness and Cognition 15(2): 358-371
Singh, B.K.; Masey, H.; Morton, R. 2006: Levels of continence in children with cerebral palsy. Paediatric Nursing 18(4): 23-26
Gente, Séphanie.; La Carbona, Séphanie.; Guéguen, M. 2007: Levels of cystathionine gamma lyase production by Geotrichum candidum in synthetic media and correlation with the presence of sulphur flavours in cheese. International Journal of Food Microbiology 114(2): 136-142
Vernal, R.; Chaparro, A.; Graumann, R.; Puente, J.; Valenzuela, M.A.; Gamonal, J. 2004: Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. Journal of Periodontology 75(12): 1586-1591
Ustundag, B.; Yilmaz, E.; Dogan, Y.; Akarsu, S.; Canatan, H.; Halifeoglu, I.; Cikim, G.; Aygun, A.D. 2005: Levels of cytokines (IL-1beta, IL-2, IL-6, IL-8, TNF-alpha) and trace elements (Zn, Cu) in breast milk from mothers of preterm and term infants. Mediators of Inflammation 6: 331-336
Davey, J.B.; Sheridan, M. 1957: Levels of dark adaptation when driving at night. British Journal of Physiological Optics 14(3): 183-189
Caldwell, B.M.; Ulett, G.A.; Mensh, I.N.; Granick, S. 1952: Levels of data in Rorschach interpretation. Journal of Clinical Psychology 8(4): 374-379
Roff, L.Lee.; Simon, C.; Klemmack, D.; Butkeviciene, R. 2006: Levels of death anxiety: a comparison of American and Lithuanian health and social service personnel. Death studies 30(7): 665-675
Kim, Y.; Duberstein, P.R.; Sörensen, S.; Larson, M.R. 2005: Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support, and caregiving burden. Psychosomatics 46(2): 123-130
Seike, N.; Miwa, T.; Otani, T.; Ueji, M. 2005: Levels of dioxins in Japanese fruit in 1999 to 2002 and estimation of their intake. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 46(6): 256-262
Healy, T.C. 2004: Levels of directiveness: a contextual analysis. Social Work in Health Care 40(1): 71-91
Primatesta, P.; Poulter, N.R. 2006: Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003. Clinical Endocrinology 64(3): 292-298
Yousefi, F. 2004: Levels of emotional awareness scale among Iranian gifted and nongifted high school students. Psychological Reports 95(2): 504-506
Soriano, A.O.; Jy, W.; Chirinos, J.A.; Valdivia, M.A.; Velasquez, H.S.; Jimenez, J.J.; Horstman, L.L.; Kett, D.H.; Schein, R.M.H.; Ahn, Y.S. 2005: Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Critical Care Medicine 33(11): 2540-2546
Pepper, H.; Lindsay, S. 1960: Levels of eosinophils, platelets, leukocytes and 17-hydroxycorticosteroids during normal menstrual cycle. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 104: 145-147
Tat, R.J.; Lewis, A.E. 1962: Levels of equivalence for various measurements of coumarin activity. JAMA 180: 744-746
Wright, J.G.; Swiontkowski, M.; Heckman, J.D. 2006: Levels of evidence. Journal of Bone and Joint Surgery. British Volume 88(9): 1264
Malik, M.H.A.; Gambhir, A.; Porter, M.L. 2006: Levels of evidence. Journal of Bone and Joint Surgery. British Volume 88(9): 1265
Graham, A.J.; Gelfand, G.; McFadden, S.D.; Grondin, S.C. 2004: Levels of evidence and grades of recommendations in general thoracic surgery. Canadian Journal of Surgery. Journal Canadien de Chirurgie 47(6): 461-465
Lau, S.L.; Samman, N. 2007: Levels of evidence and journal impact factor in oral and maxillofacial surgery. International Journal of Oral and Maxillofacial Surgery 36(1): 1-5
Hentz, R.Vincent.; Meals, R.A.; Stern, P.; Manske, P.R. 2005: Levels of evidence and the Journal of Hand Surgery. Journal of Hand Surgery 30(5): 891-892
Tovey, D.; Bognolo, G. 2005: Levels of evidence and the orthopaedic surgeon. Journal of Bone and Joint Surgery. British Volume 87(12): 1591-1592
Vandenbroucke, J.P. 2006: Levels of evidence are insufficient. Nederlands Tijdschrift Voor Geneeskunde 150(45): 2485
Paik, S.; Sechrist, C.; Torabinejad, M. 2004: Levels of evidence for the outcome of endodontic retreatment. Journal of Endodontics 30(11): 745-750
Mead, C.; Javidan-Nejad, S.; Mego, M.E.; Nash, B.; Torabinejad, M. 2005: Levels of evidence for the outcome of endodontic surgery. Journal of Endodontics 31(1): 19-24
Torabinejad, M.; Kutsenko, D.; Machnick, T.K.; Ismail, A.; Newton, C.W. 2005: Levels of evidence for the outcome of nonsurgical endodontic treatment. Journal of Endodontics 31(9): 637-646
Wasserman, J.M.; Wynn, R.; Bash, T.S.; Rosenfeld, R.M. 2006: Levels of evidence in otolaryngology journals. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 134(5): 717-723
Van Everdingen, J.J.E. 2006: Levels of evidence value are useful in the evaluation of studies and results. Nederlands Tijdschrift Voor Geneeskunde 150(45): 2484
Finkelstein, A. 2005: Levels of evidence: how they help in applying study findings to clinical practice. Journal of Family Practice 54(12): 1032
De Vet, H.C.W.; van Tulder, M.W.; Bouter, L.M. 2003: Levels of evidence: intellectual aid or absolute judgement?. Journal of Clinical Epidemiology 56(9): 917
Salihu, H.M.; Aliyu, M.H.; Pierre-Louis, B.J.; Alexander, G.R. 2003: Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Maternal and Child Health Journal 7(4): 219-227
Crowley, L.G.; Demetriou, J.A.; Macdonald, I.; Kotin, P.; Kushinsky, S.; Donovan, A.J. 1962: Levels of exogenous estrogens in tissues in human mammary carcinoma. Surgical Forum 13: 103-104
Singer, P.N.; Galen 1997: Levels of explanation in Galen. Classical Quarterly 47(2): 525-542
Xie, D.; Yin, D.; Wang, H.-J.; Liu, G.-T.; Elashoff, R.; Black, K.; Koeffler, H.P. 2004: Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(6): 2072-2081
Davies, G.; Cunnick, G.H.; Mansel, R.E.; Mason, M.D.; Jiang, W.G. 2004: Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clinical and Experimental Metastasis 21(1): 31-37
Ahlberg, K.; Ekman, T.; Gaston-Johansson, F. 2004: Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: a pilot study. Biological Research for Nursing 5(3): 203-210
Mazovets, O.L.; Katrukha, A.G.; Trifonov, I.R.; Bereznikova, A.V.; Deev, A.D.; Gratsianskiĭ, N.A. 2006: Levels of fatty acid binding protein before and after direct current cardioversion of atrial fibrillation or flutter in patients without acute coronary syndrome. Kardiologiia 46(3): 43-48
Farah, R.; Makhoul, N. 2006: Levels of fibrinogen compared to crp in plasma as new marker in diagnosis of pulmonary edema of non septic origin. Harefuah 145(12): 870
Kostić, M.; Krajovan, R. 1966: Levels of free and acetylized PAS in the blood after the administration ALPAS. Tuberkuloza 18(5): 469-476
Grimsholm, O.; Rantapää-Dahlqvist, S.; Forsgren, S. 2005: Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Research and Therapy 7(3): R416-R426
Takahashi, A.; Horie, O.; Murayama, T.; Ryo, R.; Saigo, K. 2003: Levels of granzyme B, perforin and Fas ligand antigens and mRNAs in patients following allogeneic hematopoietic stem cell transplantation. Rinsho Byori. Japanese Journal of Clinical Pathology 51(12): 1167-1173
Powell, E.D. 1960: Levels of haemoglobin in an adolescent population in Dublin. Journal of the Irish Medical Association 46: 157-161
Haverkate, F. 2002: Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vascular Pharmacology 39(3): 109-112
Bartz, K.W.; Hamerman, D.; Reife, A. 1956: Levels of hexosamine and hexose in plasma and urine in patients with certain diseases or injuries. Journal of Laboratory and Clinical Medicine 48(5): 729-734
Horobets', R.M.; Hodlevsk'kyĭ, A.I.; Pentiuk, O.O. 2003: Levels of homocysteine and interleukin-6 as a prognostic factor of complications in acute cholecystitis. Klinichna Khirurhiia 8: 23-24
Frattini, J.F. 1959: Levels of human gamma globulin with two different types of mixed typhoid-paratyphoid vaccine (TAB). Revista de la Sanidad Militar Argentina 58: 212-218
Medková, Z.; Hejnar, P. 2003: Levels of immunoglobulins of isotype IgG and IgG2 in subjects lacking formation of IgG antibodies against lipopolysaccharide of Chlamydia. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia 147(1): 77-79
Fogel, L.J. 1961: Levels of intelligence in decision making. Annals of the new York Academy of Sciences 89: 732-751
Vernal, R.; Dutzan, N.ás.; Chaparro, A.; Puente, J.; Antonieta Valenzuela, M.ía.; Gamonal, J. 2005: Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. Journal of Clinical Periodontology 32(4): 383-389
Oktem, S.; Yavuzsen, T.U.; Sengül, B.; Akhunlar, H.; Akar, S.; Tunca, M. 2004: Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Clinical and Experimental Rheumatology 22(4 Suppl 34: S34-S36
Tuncer, B.B.ş; Ozmeriç, N.; Tuncer, C.; Teoman, I.; Cakilci, B.; Yücel, A.şe.ül.; Alpar, R.; Baloş, K.ök. 2005: Levels of interleukin-8 during tooth movement. Angle Orthodontist 75(4): 631-636
Tracey, T.J.G. 2004: Levels of interpersonal complementarity: a simplex representation. Personality and Social Psychology Bulletin 30(9): 1211-1225
Yin, H.-Q.; Qiao, Z.-H.; Zhu, L.; Zhang, L.; Su, L.-P.; Lu, Y.-J. 2006: Levels of intracellular IL-6 and IFN-gamma in children with acute lymphoblastic leukemia. Zhongguo Dang Dai Er Ke Za Zhi 8(6): 461-463
Wang, L.-J.; Yang, Y.-H.; Lin, Y.-T.; Chiang, B.-L. 2006: Levels of intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with Henoch-Schönlein purpura. Journal of Microbiology Immunology and Infection 39(2): 109-113
Doggen, C.J.M.; Rosendaal, F.R.; Meijers, J.C.M. 2006: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors Xi and XIi. Blood 108(13): 4045-4051
Mujica, N.; Arteta, J.é M. 2003: Levels of lead in Venezuelan people with no occupational exposure. Salud Publica de Mexico 45(Suppl 2): S275-S278
Saczko, J.; Kulbacka, J.; Chwiłkowska, A.; Lugowski, M.; Banaś, T. 2004: Levels of lipid peroxidation in A549 cells after PDT in vitro. Roczniki Akademii Medycznej W Bialymstoku 49(Suppl 1): 82-84
Yilmaz, M.; Biri, A.; Bukan, N.; Karakoç, A.; Sancak, B.; Törüner, Füsun.; Paşaoğlu, H. 2005: Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 20(5): 258-263
Polat, G.; Tamer, L.; Tanriverdi, K.; Gürkan, E.; Baslamisli, F.; Atik, U. 2002: Levels of malondialdehyde, glutathione and ascorbic acid in idiopathic thrombocytopaenic purpura. East African Medical Journal 79(8): 446-449
Raitio, A.; Tuomas, H.; Kokkonen, N.; Salo, T.; Sorsa, T.; Hanemaaijer, R.; Oikarinen, A. 2005: Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Archives of Dermatological Research 297(6): 242-248
Cantarella, G.; Cantarella, R.; Caltabiano, M.; Risuglia, N.; Bernardini, R.; Leonardi, R. 2006: Levels of matrix metalloproteinases 1 and 2 in human gingival crevicular fluid during initial tooth movement. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 130(5): 568.E11-16
Söder, B.; Airila Månsson, S.; Söder, P-O.; Kari, K.; Meurman, J. 2006: Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. Journal of Periodontal Research 41(5): 411-417
Bagg, M.R.; Covey, D.C.; Powell, E.T. 2006: Levels of medical care in the global war on terrorism. Journal of the American Academy of Orthopaedic Surgeons 14(10 Spec No.): S7-S9
Bennett, P.; Williams, Y.; Page, N.; Hood, K.; Woollard, M. 2004: Levels of mental health problems among UK emergency ambulance workers. Emergency Medicine Journal: Emj 21(2): 235-236
Clarke, M.T.; Lee, P.T.H.; Arora, A.; Villar, R.N. 2003: Levels of metal ions after small- and large-diameter metal-on-metal hip arthroplasty. Journal of Bone and Joint Surgery. British Volume 85(6): 913-917
Maeso, G.; Bravo, M.; Bascones, A. 2007: Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva. Quintessence International 38(3): 247-252
Goertzel, B. 2005: Levels of mind versus levels of being. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 41(5): 727-729
Lundgren, H.P.; Ward, W.H. 1962: Levels of molecular organization in alpha-keratins. Archives of Biochemistry and Biophysics Suppl 1: 78-111
Corrales, R.M.; Calonge, M.; Herreras, J.M.; Saez, V.; Mayo, A.; Chaves, F.J. 2003: Levels of mucin gene expression in normal human conjunctival epithelium in vivo. Current Eye Research 27(5): 323-328
Kimchi, N.A.; Ron, Y.; Abramowich, D.; Shirin, H.; Scapa, E.; Avni, Y. 2005: Levels of muscle enzymes in the serum after esophageal pneumatic dilation in patients with achalasia. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 18(5): 332-334
Vadászová, A.; Hudecová, S.; Krizanová, O.; Soukup, T. 2006: Levels of myosin heavy chain mRNA transcripts and content of protein isoforms in the slow soleus muscle of 7 month-old rats with altered thyroid status. Physiological Research 55(2): 221-225
Brunborg, L.A.; Graff, I.E.; Frøyland, L.; Julshamn, K.år. 2006: Levels of non-essential elements in muscle from harp seal (Phagophilus groenlandicus) and hooded seal (Cystophora cristata) caught in the Greenland Sea area. Science of the Total Environment 366(2-3): 784-798
Tauheed, S.; Shoaib, S.; ul Haque, M.N. 2003: Levels of non-high density lipoprotein cholesterol (non-HDL-C) in patients with ischaemic heart disease. Journal of Ayub Medical College Abbottabad: Jamc 15(1): 33-34
Namysłowski, G.; Sobczak, A.; Uhma, E. 2003: Levels of nonenzymatic antioxidants depending on stage of laryngeal cancer. Otolaryngologia Polska 57(2): 237-241
Hoffmann, G.T.; Rottino, A.; Albaum, H. 1951: Levels of nucleotide in the blood during shock. Science 114(2955): 188-189
Gobba, F.; Rossi, P.; Roccatto, L. 2003: Levels of occupational exposure to extremely low frequency magnetic fields among workers in different jobs. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 25 Suppl (3): 214-215
Thomas, L.S.; Valli, A. 2006: Levels of occupational stress in doctors working in a South African public-sector hospital. South African Medical Journal 96(11): 1162-1168
Lyons, J.J.; Melas, M.G.; Covert, S.V. 1957: Levels of oleandomycin and evaluation of clinical uses in abnormal cerebrospinal fluid systems. Antibiotics Annual 5: 787-791
Struciński, Pł.; Ludwicki, J.K.; Góralczyk, K.; Czaja, K.; Olszewski, Włodzimierz.; Jethon, Józef.; Barańska, J.; Hernik, A. 2002: Levels of organochlorine insecticides in Polish women's breast adipose tissue, in years 1997-2001. Roczniki Panstwowego Zakladu Higieny 53(3): 221-230
Erdoğrul, O.; Covaci, A.; Kurtul, N.; Schepens, P. 2004: Levels of organohalogenated persistent pollutants in human milk from Kahramanmaraş region, Turkey. Environment International 30(5): 659-666
Seemann, R.; Hägewald, S.J.; Sztankay, V.; Drews, J.; Bizhang, M.; Kage, A. 2004: Levels of parotid and submandibular/sublingual salivary immunoglobulin a in response to experimental gingivitis in humans. Clinical Oral Investigations 8(4): 233-237
Vallada, H.P.; Ashcar, H. 1953: Levels of penicillin in the cerebrospinal fluid after parenteral administration of large doses of crystallin penicillin G. Revista do Instituto Adolfo Lutz 13: 131-139
Krech, D.; Calvin, A. 1953: Levels of perceptual organization and cognition. Journal of Abnormal Psychology 48(3): 394-400
Pickrel, E.W. 1957: Levels of perceptual organization and cognition: conflicting evidence. Journal of Abnormal Psychology 54(3): 422-424
Guitart, R.; Clavero, R.; Mateo, R.; Máñez, M. 2005: Levels of persistent organochlorine residues in eggs of greater flamingos from the Guadalquivir marshes (Doñana), Spain. Journal of Environmental Science and Health. Part. B Pesticides Food Contaminants and Agricultural Wastes 40(5): 753-760
De Felip, E.; Ingelido, A.M. 2004: Levels of persistent toxic substances in the general population in Italy. Annali Dell'istituto Superiore di Sanita 40(4): 411-415
Bieleski, R.L. 1968: Levels of phosphate esters in spirodela. Plant Physiology 43(8): 1297-1308
Kurozawa, Y.; Hosoda, T.; Iwai, N.; Nose, T.; Yoshimura, T.; Tamakoshi, A. 2005: Levels of physical activity among participants in the JACC study. Journal of Epidemiology 15 Suppl. 1: S43-S47
Liou, Y-Mei.; Chiang, L-Chi. 2004: Levels of physical activity among school-age children in Taiwan: a comparison with international recommendations. Journal of Nursing Research: Jnr 12(4): 307-316
Schifrin, A.; Kooperstein, S.I.; Leahy, T. 1962: Levels of physiologic leukocytosis. New York State Journal of Medicine 62: 2699-2707
Klimek, M.; Pabian, W.; Tomaszewska, B.; Kołodziejczyk, J. 2005: Levels of plasma ACTH in men from infertile couples. Neuro Endocrinology Letters 26(4): 347-350
Jalil, J.E.; Palomera, C.án.; Ocaranza, M.ía.P.; Godoy, I.án.; Román, M.; Chiong, M.; Lavandero, S. 2003: Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype. American Journal of Cardiology 92(6): 749-751
Carmona-Fonseca, J. 2003: Levels of plasma cholinesterase in Colombian working-class populations. Biomedica: Revista del Instituto Nacional de Salud 23(4): 437-455
He, X.-F.; Wen, Z.-B.; Liu, M.-J.; Zhang, H.; Li, Q.; He, S.-L. 2004: Levels of plasma des-gamma-carboxy protein C and prothrombin in patients with liver diseases. World Journal of Gastroenterology 10(20): 3073-3075
Wang, S.-f.; Xu, J.-c.; Liang, Q.-x. 2006: Levels of plasma interleukin-18 and interferon-gamma in patients with coronary heart disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18(4): 237-239
Shin, S.K.; Kim, T.S. 2006: Levels of polychlorinated biphenyls (PCBs) in transformer oils from Korea. Journal of Hazardous Materials 137(3): 1514-1522
Gemmell, N. 2003: Levels of polymorphism on the sex-limited chromosome: a clue to y from W?. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 25(12): 1249
Polacek, E.; Homolka, J. 1950: Levels of potassium and total calcium in infants during treatment of severe diarrhea with dehydration. Pediatricke Listy 5(6): 321-322
Adams, M.H.; Sherrod, R.A.; Packa, D.R.; Forte, L.; Lammon, C.A.; Stover, L.M.; Morrison, R.S.; Barrett, J.C. 2001: Levels of prevention: restructuring a curriculum to meet future healthcare needs. Nurse Educator 26(1): 6-8
Ho, L.; Shea, J.B. 1978: Levels of processing and the coding of position cues in motor short-term memory. Journal of Motor Behavior 10(2): 113-121
Newell, B.R.; Andrews, S. 2004: Levels of processing effects on implicit and explicit memory tasks: using question position to investigate the lexical-processing hypothesis. Experimental Psychology 51(2): 132-144
Lespinet-Najib, V.ér.; N'Kaoua, B.; Sauzéon, H.él.èn.; Bresson, C.; Rougier, A.; Claverie, B. 2004: Levels of processing with free and cued recall and unilateral temporal lobe epilepsy. Brain and Language 89(1): 83-90
Gross, N.D.; Boyle, J.O.; Morrow, J.D.; Williams, M.K.; Moskowitz, C.S.; Subbaramaiah, K.; Dannenberg, A.J.; Duffield-Lillico, A.J. 2005: Levels of prostaglandin e metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(16): 6087-6093
Hazelzet, J.A. 2006: Levels of protein C and activated protein C: what do they mean?. Critical Care 10(2): 126
Gerkowicz, T.; Krawczynsk, J. 1954: Levels of proteins and glucose in the spinous process obtained by puncture biopsy in infant nutrition disorders. Pediatria Polska 29(7): 687-692
Stríbrný, J.; Borovicka, J.; Sokol, M. 2003: Levels of psilocybin and psilocin in various types of mushrooms. Soudni Lekarstvi 48(3): 45-49
Forrest, C.M.; Gould, S.R.; Darlington, L.G.; Stone, T.W. 2003: Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Advances in Experimental Medicine and Biology 527: 395-400
Nishi, A.; Scherbaum, O.H. 1962: Levels of pyridine nucleotides and DPNH oxidase activity in growing and stationary protozoan cultures. Biochimica et Biophysica Acta 65: 411-418
Gallagher, C.H.; Rees, K.R. 1960: Levels of pyridine nucleotides in liver poisoning. Nature 187: 148-149
Zanetti, M.; Cutrufelli, F. 1961: Levels of radioactivity found in some specimens of permanent and migrating birds. Nuovi Annali d'Igiene E Microbiologia 12: 405-411
Carroll, K.K. 1962: Levels of radioactivity in tissues and in expired carbon dioxide after administration of 1-C14-labelled palmitic acid, 2-C14-labelled erucic acid, or 2-C14-labelled nervonic acid to rats. Canadian Journal of Biochemistry and Physiology 40: 1229-1238
Blatt, S.J.; Zohar, A.; Quinlan, D.M.; Luthar, S. 1996: Levels of relatedness within the dependency factor of the depressive experiences questionnaire for adolescents. Journal of Personality Assessment 67(1): 52-71
Kreis, B. 1960: Levels of resistance clinically significant for antibacilli medication. Pathologie et Biologie 8: 1659-1666
Bisset, J.A.; Rodríguez, M.ía.M.; Cáceres, L. 2003: Levels of resistance to insecticides and their mechanisms in 2 strains of Aedes aegypti from Panama. Revista Cubana de Medicina Tropical 55(3): 191-195
Cogo, R.; Raschi, S. 1996: Levels of sIgA in patients suffering from chronic bronchitis at the breakthrough stage, treated with rokitamycin. Le Infezioni in Medicina 4(2): 87-92
Ruano, R. 1952: Levels of salicylemia. Revista Medica de Costa Rica 11(214): 9-12
García Durán, A.; Docobo Durántez, F.; Mena Robles, J.; Cárave López Becerra, A.; Vázquez Monchul, J.; Durán Ferreras, I. 2003: Levels of satisfaction and perceived quality in a day surgery unit of a tertiary referral hospital. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 95(12): 851-862
Edwards, R.; Hasselholdt, C.P.; Hargreaves, K.; Probert, C.; Holford, R.; Hart, J.; Van Tongeren, M.; Watson, A.F.R. 2006: Levels of second hand smoke in pubs and bars by deprivation and food-serving status: a cross-sectional study from North West England. Bmc Public Health 6: 42
Bernhoft, A.; Skaare, J.U. 1994: Levels of selected individual polychlorinated biphenyls in different tissues of harbour seals (phoca vitulina) from the Southern coast of Norway. Environmental Pollution 86(1): 99-107
Struciński, P.ł; Góralczyk, K.; Ludwicki, J.K.; Czaja, K.; Hernik, A.; Korcz, W. 2006: Levels of selected organochlorine insecticides, polychlorinated biphenyls, phthalates and perfluorinated aliphatic substances in blood--Polish WWF study. Roczniki Panstwowego Zakladu Higieny 57(2): 99-112
Bagci, S.; Ercin, C.N.; Yesilova, Z.; Ozcan, A.; Degertekin, B.; Dagalp, K. 2006: Levels of serologic markers of celiac disease in patients with reflux esophagitis. World Journal of Gastroenterology 12(41): 6707-6710
Hirano, H.; Tone, Y.; Otani, H.; Oya, M.; Kimura, K.; Saika, Y.; Fujii, R.; Mune, M.; Ichinose, M.; Yukawa, S. 2004: Levels of serum ascorbate and its metabolites in hemodialysis patients. Nihon Jinzo Gakkai Shi 46(5): 426-433
An, J.-D.; Zhang, Y.-P.; Zhou, J.-H. 2006: Levels of serum brain natriuretic peptide in children with congestive heart failure or with severe pneumonia. Zhongguo Dang Dai Er Ke Za Zhi 8(3): 201-204
Cao, L.-F.; Lu, Y.-M.; Ma, M.; Xue, H.-Y.; Zhao, Y.; Yu, H.-Q.; Mao, H.-Y.; Gu, Y.-Y. 2006: Levels of serum interleukin-15 and the expression of T-helper lymphocyte subsets in peripheral blood of children with juvenile rheumatoid arthritis. Zhongguo Dang Dai Er Ke Za Zhi 8(1): 9-12
Xu, J.-P.; Shao, X.-M.; Zeng, J.-H. 2007: Levels of serum parathyroid hormone in neonates with asphyxia. Zhongguo Dang Dai Er Ke Za Zhi 9(1): 71-72
Ohnishi, K.; Kato, Y. 2002: Levels of serum vascular cell adhesion molecule-1 in measles. Southeast Asian Journal of Tropical Medicine and Public Health 33(4): 852-854
Baĭkova, O.A.; Liusov, V.A.; Evsikov, E.M.; Oshnokova, A.A.; Magomedova, A.A. 2004: Levels of sex hormones in obese women with hypertension during various periods of reproductive activity. Kardiologiia 44(3): 52-57
Vargues, R.; Grenier, B. 1960: Levels of so-called "natural" antibodies and hypergammaglobulinemia. Annales de l'Institut Pasteur 98: 728-733
Graymore, C.; Towlson, M. 1963: Levels of soluble NAD-linked alpha-glycerophosphate dehydrogenase and lactic acid dehydrogenase in rat retina. Experimental Eye Research 2: 48-52
Passam, F.H.; Tsirakis, G.; Boula, A.; Fragou, A.; Consolas, I.; Alegakis, A.; Kyriakou, D.S.; Alexandrakis, M.G. 2004: Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. Clinical and Laboratory Haematology 26(6): 391-395
Basoglu, M.; Yildirgan, M.I.; Taysi, S.; Yilmaz, I.; Kiziltunc, A.; Balik, A.A.; Celebi, F.; Atamanalp, S.S. 2003: Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer. Journal of Surgical Oncology 83(3): 180-184
Lamszus, K.; Ulbricht, U.; Matschke, J.; Brockmann, M.A.; Fillbrandt, R.; Westphal, M. 2003: Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(4): 1399-1405
Dotsenko, E.A.; Yupatov, G.I.; Goridovets, T.N.; Dotsenko, M.L. 2005: Levels of some antiviral antibodies in patients with different serum content of total cholesterol. Bulletin of Experimental Biology and Medicine 139(1): 89-90
Reynolds, G.Shawn.; Lehman, W.E.K. 2003: Levels of substance use and willingness to use the Employee Assistance Program. Journal of Behavioral Health Services and Research 30(2): 238-248
Meng, Z.; Li, R.; Zhang, X. 2005: Levels of sulfite in three organs from mice exposed to sulfur [corrected] dioxide. Inhalation Toxicology 17(6): 309-313
Oppo, G.T. 1957: Levels of sulfocyanathemia in a normal woman and in some diseases of the genital system. Bollettino della Societa Italiana di Biologia Sperimentale 33(1-2): 26-28
Kapoor, P.; Kharbanda, O.P. 2005: Levels of t-PA and PAI-2 in gingival crevicular fluid during orthodontic tooth movement in adults. Australian orthodontic journal 21(2): 151-2; author reply 152-3
Acladious, N.N.; Harrison, K.L.; Sutton, C.J.; Povey, A.C.; Mandal, D.; Kitchener, H. 2004: Levels of the DNA adduct, N7-methyldeoxyguanosine, are associated with increased risk of failure of treatment of cervical intraepithelial neoplasia. Gynecologic Oncology 93(3): 605-609
Scorza, C.A.; Garrido, Y.d.C.; Arida, R.M.; Amado, D.; Cavalheiro, E.A.ão.; Naffah-Mazzacoratti, M.d.G.ça. 2003: Levels of the synaptic protein X11 alpha/mint1 are increased in hippocampus of rats with epilepsy. Epilepsy Research 57(1): 49-57
Ramoa, A.; Maia, Sé.; Lourenço, Aália. 2017: A Rational Framework for Production Decision Making in Blood Establishments. Journal of Integrative Bioinformatics 9(3): 69-79
Soliman, F.A.; Badawi, H.M. 1956: Levels of thyroid and thyrotrophic hormones in the blood of rats at various stages of the oestrous cycle. Nature 177(4501): 235
Hensley, M.E.; Ke, W.; Hayden, R.T.; Handgretinger, R.; McCullers, J.A. 2004: Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unit. Journal of Pediatric Oncology Nursing: Official Journal of the Association of Pediatric Oncology Nurses 21(2): 67-78
Raynaud, P. 1957: Levels of total nitrogen in the rumen of small ruminants having a permanent fistula. Archives des Sciences Physiologiques 11(2): 69-75
Andersen, G.; Føreid, S.; Skaare, J.U.; Jenssen, B.M.; Lydersen, C.; Kovacs, K.M. 2006: Levels of toxaphene congeners in white whales (Delphinapterus leucas) from Svalbard, Norway. Science of the Total Environment 357(1-3): 128-137
McNeill, A.; Bedi, R.; Islam, S.; Alkhatib, M.N.; West, R. 2006: Levels of toxins in oral tobacco products in the UK. Tobacco Control 15(1): 64-67
Andres, J.; Stepień, E.; Szajna-Zych, M.; Drwiła, R.; Zietkiewicz, M.; Sadowski, J.; Kapelak, B.; Dziatkowiak, A. 2001: Levels of troponin I, tropoinin T, isoenzyme MB creatine kinase and myoglobins in blood serum for perioperative diagnosis of myocardial infarction in patients after coronary artery bypass graft surgery with extracorporeal circulation. Folia Medica Cracoviensia 42(4): 263-271
Cağatay, T.ül.; Kiran, B.; Yurt, S.; Gülbaran, Z.; Kosar, F.; Cağatay, P. 2005: Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis. Respirology 10(3): 290-294
Gil'miiarova, F.N.; Pervova, I.V.; Radomskaia, V.M.; Gergel', N.I.; Tarasova, S.V. 2004: Levels of unified metabolites and thyroid hormones in blood and oral fluid of children with minimal brain dysfunction. Biomeditsinskaia Khimiia 50(2): 204-210
Tashiro, K.; Koyanagi, I.; Ohara, I.; Ito, T.; Saitoh, A.; Horikoshi, S.; Tomino, Y. 2004: Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. Journal of Clinical Laboratory Analysis 18(3): 206-210
Zalewski, B. 2004: Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World Journal of Gastroenterology 10(4): 583-585
Caricato, A.; Pennisi, M.; Mancino, A.; Vigna, G.; Sandroni, C.; Arcangeli, A.; Antonelli, M. 2006: Levels of vancomycin in the cerebral interstitial fluid after severe head injury. Intensive Care Medicine 32(2): 325-328
Hang, C.-H.; Shi, J.-X.; Li, J.-S.; Wu, W.; Li, W.-Q.; Yin, H.-X. 2004: Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction. World Journal of Gastroenterology 10(6): 875-880
Masi, A.; Moggi, P. 1951: Levels of viomycin in blood, cerebrospinal fluid and urine. Rivista di Clinica Pediatrica 49(12): 865-870
Huang, X.; Li, X.; Fan, X.; Liu, H. 2002: Levels of volatile sulfur compounds and the analysis of related factors in oral cavities of 384 health subjects in Chengdu. Hua Xi Kou Qiang Yi Xue Za Zhi 20(5): 380-382
Kahane, E.; Levey, J. 1951: Levels of water-soluble choline in mice kept on a starvation diet or on a deficient diet. Bulletin de la Societe de Chimie Biologique 33(8): 990-992
Cumurcu, T.; Mendil, D.; Etikan, I. 2006: Levels of zinc, iron, and copper in patients with pseudoexfoliative cataract. European Journal of Ophthalmology 16(4): 548-553
Licata, P.; Trombetta, D.; Cristani, M.; Giofrè, F.; Martino, D.; Calò, M.; Naccari, F. 2004: Levels of "toxic" and "essential" metals in samples of bovine milk from various dairy farms in Calabria, Italy. Environment International 30(1): 1-6
Ragland, J.D.; McCarthy, E.; Bilker, W.B.; Brensinger, C.M.; Valdez, J.; Kohler, C.; Gur, R.E.; Gur, R.C. 2006: Levels-of-processing effect on internal source monitoring in schizophrenia. Psychological Medicine 36(5): 641-648
Royet, J.-P.; Koenig, O.; Paugam-Moisy, H.; Puzenat, D.; Chasse, J.-L. 2004: Levels-of-processing effects on a task of olfactory naming. Perceptual and Motor Skills 98(1): 197-213
Parinov, V.S. 1957: Lever and classical methods of application of obstetric forceps. Akusherstvo i Ginekologiia 33(2): 50-53
Pear, J.J.; Hemingway, M.J.; Keizer, P. 1978: Lever attacking and pressing as a function of conditioning and extinguishing a lever-press avoidance response in rats. Journal of the Experimental Analysis of Behavior 29(2): 273-282
Pear, J.J.; Moody, J.E.; Persinger, M.A. 1972: Lever attacking by rats during free-operant avoidance. Journal of the Experimental Analysis of Behavior 18(3): 517-523
Herrick, R.M. 1963: Lever displacement during continuous reinforcement and during a discrimination. Journal of Comparative and Physiological Psychology 56: 700-707
Moroni, I. 1952: Lever for extractions. Rassegna Odontotecnica 33(1): 60
Campbell, S.L. 1962: Lever holding and behavior sequences in shock-escape. Journal of Comparative and Physiological Psychology 55: 1047-1053
Hong, R-Ki.; Heo, J-Min.; Ha, Y-Ki. 2005: Lever-arm and mini-implant system for anterior torque control during retraction in lingual orthodontic treatment. Angle Orthodontist 75(1): 129-141
Singh, K.P.; Ropars, G.; Brunel, M.; Le Floch, A. 2003: Lever-assisted two-noise stochastic resonance. Physical Review Letters 90(7): 073901
Stiers, M.; Silberberg, A. 1974: Lever-contact responses in rats: automaintenance with and without a negative response-reinforcer dependency. Journal of the Experimental Analysis of Behavior 22(3): 497-506
Van Staey, J. 1958: Lever-echinococcosis. Belgisch Tijdschrift Voor Geneeskunde 14(16): 792-795
Bairov, G.A. 1955: Lever-protector for osteotomy in children. Vestnik Khirurgii Imeni I. I. Grekova 75(5): 126
Hlavinka, K. 2002: Leverage and the hard hospital professional market. Journal of Healthcare Risk Management: the Journal of the American Society for Healthcare Risk Management 22(2): 23-26
Levin, R. 2005: Leverage in dentistry. Journal of the American Dental Association 136(1): 87-88
Amatayakul, M. 2003: Leveraging HIPAA to improve IT planning. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 57(11): 88-89
Rendin, R.W.; Welch, N.M.; Kaplowitz, L.G. 2005: Leveraging bioterrorism preparedness for non-bioterrorism events: a public health example. Biosecurity and Bioterrorism: Biodefense Strategy Practice and Science 3(4): 309-315
Rogers, T.; Barker, D.C.; Siebold, W.L. 2005: Leveraging funds for public health improvement: tobacco settlement funds as an opportunity to transform public health. Journal of Public Health Management and Practice: Jphmp 11(2): 170-173
Breslin, P.T. 2003: Leveraging hospital investment in ER services. Health Care Strategic Management 21(9): 1; 12-15
Ball, M.J.; Garets, D.E.; Handler, T.J. 2003: Leveraging information technology towards enhancing patient care and a culture of safety in the US. Methods of Information in Medicine 42(5): 503-508
Zaidi, S.Zahid.Hassan.; Abidi, S.Sibte.Raza.; Manickam, S. 2002: Leveraging intelligent agents for knowledge discovery from heterogeneous healthcare data repositories. Studies in Health Technology and Informatics 90: 335-340
Donaldson, N.; Brown, D.Storer.; Aydin, C.E.; Bolton, M.Linda.Burnes.; Rutledge, D.N. 2005: Leveraging nurse-related dashboard benchmarks to expedite performance improvement and document excellence. Journal of Nursing Administration 35(4): 163-172
Afrin, L.B.; Oates, J.C.; Boyd, C.K.; Daniels, M.S. 2003: Leveraging of open EMR architecture for clinical trial accrual. AMIA . Annual Symposium Proceedings. AMIA Symposium 2003: 16-20
Rempher, K.J.; Lasome, C.E.M.; Lasome, T.J. 2003: Leveraging palm technology in the advanced practice nursing environment. AACN Clinical Issues 14(3): 363-370
Chan, A.S.; Shankar, R.D.; Coleman, R.W.; Matins, S.B.; Hoffman, B.B.; Goldstein, M.K. 2005: Leveraging point-of-care clinician feedback to study barriers to guideline adherence. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2005: 915
Moore, J.; Abdul-Manan, N.; Fejzo, J.; Jacobs, M.; Lepre, C.; Peng, J.; Xie, X. 2004: Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design. Journal of Synchrotron Radiation 11(Part 1): 97-100
Koo, D. 2005: Leveraging syndromic surveillance. Journal of Public Health Management and Practice: Jphmp 11(3): 181-183
Hoagland, C.; Zar, N.; Nelson, H. 2007: Leveraging technology to drive revenue cycle results. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 61(2): 70-76
Carr, K.; Bangalore, D.; Benin, A.; Holmboe, E.S. 2006: Leveraging the benefits of Health Information Technology to support healthcare delivery model redesign. Journal of Healthcare Information Management: Jhim 20(1): 31-41
Hearne, S.A.; Segal, L.M. 2003: Leveraging the nation's anti-bioterrorism investments: foundation efforts to ensure a revitalized public health system. Health Affairs 22(4): 230-234
Anonymous 2005: Leveraging the power of EMRs to drive DM. Disease Management Advisor 11(10): 118-20 109
James, M.; Hoff, T.; Davis, J.; Graham, R. 2005: Leveraging the power of the media to combat HIV/AIDS. Health Affairs 24(3): 854-857
Henzlik, J.; Fallender, S. 2003: Leveraging the power of the proxy. Catholic health care systems are using stock holdings to push for corporate accountability. Health Progress 84(4): 36-39
Rapaille, G.C. 2006: Leveraging the psychology of the salesperson. a conversation with psychologist and anthropologist G. Clotaire Rapaille. Harvard Business Review 84(7-8): 42; 44-186
Frazee, S.Glave.; Kirkpatrick, P.; Fabius, R.; Chimera, J. 2007: Leveraging the trusted clinician: documenting disease management program enrollment. Disease Management: Dm 10(1): 16-29
Barrera, L.; Benner, C.; Tao, Y-Chuan.; Winzeler, E.; Zhou, Y. 2004: Leveraging two-way probe-level block design for identifying differential gene expression with high-density oligonucleotide arrays. Bmc Bioinformatics 5: 42
Atreja, A.; Sharp, J.; Mehta, N. 2006: Leveraging web-based team collaboration environment for clinical, research and education in a tertiary care academic hospital. AMIA . Annual Symposium Proceedings. AMIA Symposium 2006: 848
Bjerke, N.B. 2006: Leveraging your culture for change. Critical Care Nursing Quarterly 29(2): 132-136
Rekow, E.D. 2006: Leveraging your research--mapping our future. Journal of Dental Research 85(7): 583
Albeck, D.S.; Beck, K.D.; Kung, L.-H.; Sano, K.; Brennan, F.X. 2005: Leverpress escape/avoidance training increases neurotrophin levels in rat brain. Integrative Physiological and Behavioral Science: the Official Journal of the Pavlovian Society 40(1): 28-34
Penovich, P.E.. 2002: Levetiracetam and Oral Contraceptives. Epilepsy Currents 2(6): 182
Kumar, S.P.; Smith, P.E.M. 2004: Levetiracetam as add-on therapy in generalised epilepsies. Seizure 13(7): 475-477
Gao, L.; Jin, Y.; Liu, X.; Xu, M.; Lai, X.; Shui, J. 2018: A rationally assembled graphene nanoribbon/graphene framework for high volumetric energy and power density Li-ion batteries. Nanoscale 10(16): 7676-7684
Cochran, J.W. 2004: Levetiracetam as migraine prophylaxis. Clinical Journal of Pain 20(3): 198-199
Della Marca, G.; Vollono, C.; Mariotti, P.; Mazza, M.; Mennuni, G.F.; Tonali, P.; Mazza, S. 2006: Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases. Journal of Neurology Neurosurgery and Psychiatry 77(4): 566-567
Weiner, M.F.; Womack, K.B.; Martin-Cook, K.; Svetlik, D.A.; Hynan, L.S. 2005: Levetiracetam for agitated Alzheimer's disease patients. International Psychogeriatrics 17(2): 327-328
Bello-Espinosa, L.E.; Roberts, S.L. 2003: Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases. Seizure 12(3): 157-159
Kelly, K.; Stephen, L.J.; Brodie, M.J. 2004: Levetiracetam for people with mental retardation and refractory epilepsy. Epilepsy and Behavior: E&b 5(6): 878-883
Krebs, M.; Leopold, K.; Richter, C.; Kienast, T.; Hinzpeter, A.; Heinz, A.; Schaefer, M. 2006: Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial. Journal of Clinical Psychopharmacology 26(3): 347-349
Sullivan, K.L.; Hauser, R.A.; Zesiewicz, T.A. 2005: Levetiracetam for the treatment of essential tremor. Movement Disorders: Official Journal of the Movement Disorder Society 20(5): 640
Sullivan, K.L.; Hauser, R.A.; Louis, E.D.; Chari, G.; Zesiewicz, T.A. 2005: Levetiracetam for the treatment of generalized dystonia. Parkinsonism and Related Disorders 11(7): 469-471
Kinrys, G.; Wygant, L.E.; Pardo, T.B.; Melo, M. 2006: Levetiracetam for treatment-refractory posttraumatic stress disorder. Journal of Clinical Psychiatry 67(2): 211-214
Gavilán, J.C.; Bermúdez, F.; Romero, M.; González Santos, P. 2004: Levetiracetam hepatitis. Medicina Clinica 122(1): 38
Meco, G.; Fabrizio, E.; Epifanio, A.; Di Raimondo, G.; Vanacore, N.; Morgante, L. 2005: Levetiracetam in L-dopa-induced dyskinesia. Clinical Neuropharmacology 28(2): 102-103
Hmaimess, G.; Kadhim, H.; Nassogne, M.-C.éc.; Bonnier, C.; van Rijckevorsel, K. 2006: Levetiracetam in a neonate with malignant migrating partial seizures. Pediatric Neurology 34(1): 55-59
Brodtkorb, E.; Klees, T.M.; Nakken, K.O.; Lossius, R.; Johannessen, S.I. 2004: Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects. Epilepsy and Behavior: E&b 5(2): 231-235
Bersani, G. 2004: Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study. Human Psychopharmacology 19(5): 355-356
Herranz, J.L. 2003: Levetiracetam in children and adolescents with epilepsy. Revista de Neurologia 37(6): 558-560
Opp, J.; Tuxhorn, I.; May, T.; Kluger, G.; Wiemer-Kruel, A.; Kurlemann, G.; Gross-Selbeck, G.; Rating, D.; Brandl, U.; Bettendorf, U.; Härtel, C.; Korn-Merker, E. 2005: Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 14(7): 476-484
Bootsma, H.P.R.; Ricker, L.; Diepman, L.; Gehring, J.; Hulsman, J.; Lambrechts, D.; Leenen, L.; Majoie, M.; Schellekens, A.; de Krom, M.; Aldenkamp, A.P. 2007: Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy and Behavior: E&b 10(2): 296-303
Bird, J.M.; Joseph, Z.A. 2003: Levetiracetam in clinical use--a prospective observational study. Seizure 12(8): 613-616
Striano, P.; Manganelli, F.; Boccella, P.; Perretti, A.; Striano, S. 2005: Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Movement Disorders: Official Journal of the Movement Disorder Society 20(12): 1610-1614
Labate, A.; Colosimo, E.; Gambardella, A.; Leggio, U.; Ambrosio, R.; Quattrone, A. 2006: Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure 15(3): 214-218
Steinhoff, B.J.; Trinka, E.; Wieser, H.-G. 2005: Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland. Seizure 14(7): 490-496
Mohanraj, R.; Parker, P.G.; Stephen, L.J.; Brodie, M.J. 2005: Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 14(1): 23-27
Leach, J.P. 2004: Levetiracetam in the management of epilepsy. Hospital Medicine 65(12): 740-744
De Los Reyes, E.C.; Sharp, G.B.; Williams, J.P.; Hale, S.E. 2004: Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatric Neurology 30(4): 254-256
Grunze, H.; Langosch, J.; Born, C.; Schaub, G.; Walden, J.ör. 2003: Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. Journal of Clinical Psychiatry 64(7): 781-784
Mariero Klees, T.; Brodtkorb, E.; Nakken, K.O.; Lossius, R.; Johannessen, S.I. 2003: Levetiracetam in the treatment of epilepsy. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(11): 1539-1541
Deleu, D. 2004: Levetiracetam in the treatment of idiopathic hemifacial spasm. Neurology 62(11): 2134-2135
Lawlor, K.M.; Devlin, A.M. 2005: Levetiracetam in the treatment of infantile spasms. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 9(1): 19-22
Price, M.J. 2004: Levetiracetam in the treatment of neuropathic pain: three case studies. Clinical Journal of Pain 20(1): 33-36
Papacostas, S.; Kkolou, E.; Papathanasiou, E. 2007: Levetiracetam in three cases of progressive myoclonus epilepsy. Pharmacy World and Science: Pws 29(3): 164-166
Kapoor, P.; McCabe, P.; Kothari, M.J. 2005: Levetiracetam induced polyneuropathy: a case report. Electromyography and Clinical Neurophysiology 45(1): 15-17
Reis, J.; Wentrup, A.; Hamer, H.M.; Mueller, H.-H.; Knake, S.; Tergau, F.; Oertel, W.H.; Rosenow, F. 2004: Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function--a TMS study. Epilepsy Research 62(1): 41-51
Wang, H.; Gao, J.; Lassiter, T.F.; McDonagh, D.L.; Sheng, H.; Warner, D.S.; Lynch, J.R.; Laskowitz, D.T. 2006: Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocritical Care 5(1): 71-78
Long, L. 2003: Levetiracetam monotherapy during pregnancy: a case series. Epilepsy and Behavior: E&b 4(4): 447-448
Alsaadi, T.M..; Thieman, C.; Zusman, E.E.. 2002: Levetiracetam monotherapy for adults with localization-related epilepsy. Epilepsy and Behavior: E&b 3(5): 471-474
Alsaadi, T.M.; Koopmans, S.; Apperson, M.; Farias, S. 2004: Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 13(1): 58-60
Alsaadi, T.M.; Thieman, C. 2003: Levetiracetam monotherapy for newly diagnosed epilepsy patients. Seizure 12(3): 154-156
Cohen, J. 2003: Levetiracetam monotherapy for primary generalised epilepsy. Seizure 12(3): 150-153
Husum, H.; Bolwig, T.G.; Sánchez, C.; Mathé, A.A.; Hansen, S.L. 2004: Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Epilepsy and Behavior: E&b 5(2): 204-215
Marini, H.; Costa, C.; Passaniti, M.; Esposito, M.; Campo, G.M.; Ientile, R.; Adamo, E.B.; Marini, R.; Calabresi, P.; Altavilla, D.; Minutoli, L.; Pisani, F.; Squadrito, F. 2004: Levetiracetam protects against kainic acid-induced toxicity. Life Sciences 74(10): 1253-1264
Archer, D.P.; Lamberty, Y.; Wang, B.; Davis, M.J.; Samanani, N.; Roth, S.H. 2007: Levetiracetam reduces anesthetic-induced hyperalgesia in rats. Anesthesia and Analgesia 104(1): 180-185
Rocamora, R.; Wagner, K.; Schulze-Bonhage, A. 2006: Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Seizure 15(6): 428-433
Gallagher, M.J.; Eisenman, L.N.; Brown, K.M.; Erbayat-Altay, E.; Hecimovic, H.; Fessler, A.J.; Attarian, H.P.; Gilliam, F.G. 2004: Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy. Epilepsia 45(1): 90-91
Briggs, D.E.; French, J.A. 2004: Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opinion on Drug Safety 3(5): 415-424
Maschio, M.; Albani, F.; Baruzzi, A.; Zarabla, A.; Dinapoli, L.; Pace, A.; Pompili, A.; Carapella, C.M.; Occhipinti, E.; Jandolo, B. 2006: Levetiracetam therapy in patients with brain tumour and epilepsy. Journal of Neuro-Oncology 80(1): 97-100
Krauss, G.L.; Betts, T.; Abou-Khalil, B.; Gergey, G.; Yarrow, H.; Miller, A. 2003: Levetiracetam treatment of idiopathic generalised epilepsy. Seizure 12(8): 617-620
Wier, L.M.; Tavares, S.B.; Tyrka, A.R.; Price, L.H.; Carpenter, L.L. 2006: Levetiracetam-induced depression in a healthy adult. Journal of Clinical Psychiatry 67(7): 1159-1160
Kröll-Seger, J.; Mothersill, I.William.; Novak, S.; Sälke-Kellermann, R.Anneli.; Krämer, Günter. 2006: Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. Epileptic Disorders: International Epilepsy Journal with Videotape 8(3): 213-218
Zesiewicz, T.A.; Sanchez-Ramos, J.; Sullivan, K.L.; Hauser, R.A. 2005: Levetiracetam-induced parkinsonism in a Huntington disease patient. Clinical Neuropharmacology 28(4): 188-190
Sander, J.W..; Mitchell, T.N.. 2001: Levetiracetam: A new antiepileptic drug for the adjunctive therapy of chronic epilepsy. Drugs of Today 37(10): 665-673
Pinto, A.; Sander, J.W. 2003: Levetiracetam: a new therapeutic option for refractory epilepsy. International Journal of Clinical Practice 57(7): 616-621
Anonymous 2003: Levetiracetam: new preparation. For some patients with refractory partial epilepsy. Prescrire International 12(64): 53-54
Kasteleijn-Nolst Trenité, D.ée.G.A.; Hirsch, E. 2003: Levetiracetam: preliminary efficacy in generalized seizures. Epileptic Disorders: International Epilepsy Journal with Videotape 5(Suppl 1): S39-S44
Wagner, G.L.; Wilms, E.B.; Van Donselaar, C.A.; Vecht, C.J. 2003: Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12(8): 585-586
Ben-Menachem, E. 2003: Levetiracetam: treatment in epilepsy. Expert Opinion on PharmacoTherapy 4(11): 2079-2088
Salvati, A.A. 1951: Leveuf's operation in congenital hip dislocation in infant and children under 3 years of age; immediate clinical and radiological results. Prensa Pediatrica; Revista Americana de Puericultura Y Pediatria 2(12): 203-226
Chernin, D.; Shklar, G.; Parmly, L.Spear. 2003: Levi Spear Parmly: father of dental hygiene and children's dentistry in America. Journal of the History of Dentistry 51(1): 15-18
Leach, E. 1961: Levi-Strauss in the Garden of Eden: an examination of some recent developments in the analysis of myth. Transactions of the new York Academy of Sciences 23: 386-396
Brenning, R. 1959: Levin test and school performance. Svenska Lakartidningen 56: 3196-3210
Badenski, A.; Ionescu, M. 1955: Levin's medium used for differentiation of bacteria of the Shigella, Salmonella and Escherichia coli groups. Igiena 1: 84-86
Henricson, S.E.; Rodhe, G. 1960: Levin's test and scholastic performance. Svenska Lakartidningen 57: 1380-1384
Clifton-Soderstrom, M.; Levinas, E. 2003: Levinas and the patient as other: the ethical foundation of medicine. Journal of Medicine and Philosophy 28(4): 447-460
Nortvedt, P. 2003: Levinas, justice and health care. Medicine Health Care and Philosophy 6(1): 25-34
Costeas, F.; Katsareas, P.S. 1965: Levine Sign--Hellenic Tribute. New England Journal of Medicine 273: 112
Delmore, B.A. 2006: Levine's framework in long-term ventilated patients during the weaning course. Nursing Science Quarterly 19(3): 247-258
De Luca, R. 1952: Levinson's reaction in tuberculous meningitis. Acta Paediatrica Latina 5(2): 193-200
Timpano, P. 1951: Levinson's test. Rassegna Internazionale di Clinica e Terapia 31(6): 202-203
Misra, S.S.; Saxena, K.M.; Misra, R.M. 1958: Levinson's test in tuberculous meningitis. Journal of the Indian Medical Association 31(12): 480-483
Brand, J.; Häring, I.; Rost, J.-M. 2003: Levinson-like theorem for scattering from a Bose-Einstein condensate. Physical Review Letters 91(7): 070403
Pohloudek-Fabini, R. 1952: Levisticum officinale Koch. Die Pharmazie 7(7): 435-441
Scales, J.T. 1961: Levitation. Lancet 2(7213): 1181
Ghorai, P.K.; Yashonath, S. 2005: Levitation effect: Distinguishing anomalous from linear regime of guests sorbed in zeolites through the decay of intermediate scattering function and wavevector dependence of self-diffusivity. Journal of Physical Chemistry. B 109(9): 3979-3983
Sharma, M.; Bhide, S.Y.; Yashonath, S. 2005: Levitation effect: size-dependent maximum in rotational diffusion in confined systems. Journal of Chemical Physics 122(14): 144505
Flinn, E.D. 2004: Levitation yields purer glass. Aerospace America 42(2): 18-19
Katsarov, M. 2004: Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction. Akusherstvo i Ginekologiia 43(Suppl 1): 31-32
Sommer, F. 2004: Levitra in a hardness test. Krankenpflege Journal 42(3-4): 120
Esilevskiĭ, I.M.; Aliaev, I.G.; Krupinov, G.E.; Zhuchenko, T.D.; Akhvlediani, N.D. 2006: Levitra in the treatment of patients with chronic prostatitis associated with sexual dysfunction. Urologiia 6: 18-22
Ginoulhiac, E. 1951: Levo- and dextro-chloramphenicol; comparative research on rats. Bollettino della Societa Italiana di Biologia Sperimentale 27(12): 1735-1738
Jaecklin, T.; Beghetti, M.; Didier, D. 2003: Levoatriocardinal vein without cardiac malformation and normal pulmonary venous return. Heart 89(12): 1444
Astuto, M.; Disma, N.; Arena, C. 2003: Levobupivacaine 0.25% compared with ropivacaine 0.25% by the caudal route in children. European Journal of Anaesthesiology 20(10): 826-830
Piangatelli, C.; De Angelis, C.; Pecora, L.; Recanatini, F.; Cerchiara, P.; Testasecca, D. 2006: Levobupivacaine and ropivacaine in the infraclavicular brachial plexus block. Minerva Anestesiologica 72(4): 217-221
Kuczkowski, K.M. 2004: Levobupivacaine and ropivacaine: the new choices for labor analgesia. International Journal of Clinical Practice 58(6): 604-605
Rosenberg, P.H.; Schug, S.A. 2005: Levobupivacaine base and levobupivacaine hydrochloride. British Journal of Anaesthesia 94(4): 544
Frawley, G.P.; Downie, S.; Huang, G.H. 2006: Levobupivacaine caudal anesthesia in children: a randomized double-blind comparison with bupivacaine. Paediatric Anaesthesia 16(7): 754-760
Kokki, H.; Ylönen, P.; Heikkinen, M.; Reinikainen, M. 2004: Levobupivacaine for pediatric spinal anesthesia. Anesthesia and Analgesia 98(1): 64-67
Urbanek, B.; Kapral, S. 2006: Levobupivacaine for regional anesthesia. a systematic review. Der Anaesthesist 55(3): 296-313
Bremerich, D.H.; Zwissler, B. 2004: Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?. Der Anaesthesist 53(7): 637-644
Frawley, G.P.; Farrell, T.; Smith, S. 2004: Levobupivacaine spinal anesthesia in neonates: a dose range finding study. Paediatric Anaesthesia 14(10): 838-844
Ngamprasertwong, P.; Udomtecha, D.; Charuluxananan, S.; Rodanant, O.; Srihatajati, C.; Baogham, S. 2005: Levobupivacaine versus racemic bupivacaine for extradural anesthesia for cesarean delivery. Journal of the Medical Association of Thailand 88(11): 1563-1568
Fattorini, F.; Ricci, Z.; Rocco, A.; Romano, R.; Pascarella, M.A.; Pinto, G. 2006: Levobupivacaine versus racemic bupivacaine for spinal anaesthesia in orthopaedic major surgery. Minerva Anestesiologica 72(7-8): 637-644
Lee, Y.Y.; Muchhal, K.; Chan, C.K. 2003: Levobupivacaine versus racemic bupivacaine in spinal anaesthesia for urological surgery. Anaesthesia and Intensive Care 31(6): 637-641
Yang, Z.K.; Yuan, C.-Z.; Xu, A.-W. 2018: A rationally designed Fe-tetrapyridophenazine complex: a promising precursor to a single-atom Fe catalyst for an efficient oxygen reduction reaction in high-power Zn-air cells. Nanoscale 10(34): 16145-16152
Kakagia, D.; Fotiadis, S.; Tripsiannis, G. 2005: Levobupivacaine versus ropivacaine infiltration analgesia for mastopexy: a comparative study of 2 long-acting anesthetic drugs in infiltrative anesthesia for mastopexy. Annals of Plastic Surgery 55(3): 258-261
Gristwood, R.W.; Greaves, J.L. 1999: Levobupivacaine: a new safer long acting local anaesthetic agent. Expert Opinion on Investigational Drugs 8(6): 861-876
Momma, K.; Tanae, A.; Oshima, M.; Okuni, M. 1964: Levocardia with Abdominal Situs Inversus. Report of Eight Cases with Special References to their Electrocardiographic Findings. Japanese Heart Journal 5: 243-253
Voussure, G. 1959: Levocardia and situs inversus. Acta Cardiologica 14(2): 187-191
Kasparkova, O.; Kania, H. 1961: Levocardia with asplenism (Ivemark syndrome) diagnosed premortem. Ceskoslovenska Pediatrie 16: 827-831
Shibolet, S.; Riss, E.; Gafni, J. 1962: Levocardia with partial situs inversus, an incidental finding in a 15-year-old boy. American Heart Journal 63: 699-703
Donzelot, E.; Metianu, C.; Durand, M.; Guillemot, R. 1953: Levocardia: report of an anatomicoclinical case. Archives des Maladies du Coeur et des Vaisseaux 46(5): 465-471
Ney Toledo, A.; Azevedo, A.d.C.; Roubach, R.; De Carvalho, A.A. 1954: Levocardia: two case. Arquivos Brasileiros de Cardiologia 7(2): 83-108
Schreiber, B. 2005: Levocarnitine and dialysis: a review. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition 20(2): 218-243
Jorissen, M.; Bertrand, B.; Stiels, B.; Vandenbulcke, K. 2006: Levocetirizine as treatment for symptoms of seasonal allergic rhinitis. B-Ent 2(2): 55-62
Walter Canonica, G.; Bousquet, J.; Van Hammée, G.èv.; Bachert, C.; Durham, S.R.; Klimek, L.; Mullol, J.; Van Cauwenberge, P.B. 2006: Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respiratory Medicine 100(10): 1706-1715
Ciprandi, G.; Cirillo, I.G.; Vizzaccaro, A.; Tosca, M.A. 2005: Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. European Annals of Allergy and Clinical Immunology 37(1): 25-29
De Blic, J.; Wahn, U.; Billard, E.; Alt, R.; Pujazon, M.-C. 2005: Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 16(3): 267-275
Pfaar, O.; Wrede, H.; Barth, C.; Hansen, I.; Klimek, L. 2006: Levocetirizine in patients with chronic idiopathic urticaria: results of a multicenter clinical practice study. International Journal of Clinical Pharmacology and Therapeutics 44(4): 191-192
Kapp, A.; Pichler, W.J. 2006: Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. International Journal of Dermatology 45(4): 469-474
Day, J.H.; Ellis, A.K.; Rafeiro, E. 2004: Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders. Drugs of Today 40(5): 415-421
Hair, P.I.; Scott, L.J. 2006: Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 66(7): 973-996
Walsh, G.M. 2006: Levocetirizine: an update. Current Medicinal Chemistry 13(22): 2711-2715
Anonymous 2003: Levocetirizine: new preparation. Me-too: simply the active enantiomer of cetirizine. Prescrire International 12(67): 171-172
Bloebaum, R.M.; Grant, J.A. 2004: Levocetirizine: the allergist's arsenal grows larger. Expert Opinion on PharmacoTherapy 5(7): 1581-1588
Anonymous 2005: Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire International 14(76): 51-54
Borek, L.L.; Friedman, J.H. 2005: Levodopa addiction in idiopathic Parkinson disease. Neurology 65(9): 1508
Leiva-Santana, C.; Alvarez-Saúco, M. 2006: Levodopa and cognitive disorders in Parkinson's disease. Revista de Neurologia 43(2): 95-100
Morgan, J.; Sethi, K.D. 2005: Levodopa and the progression of Parkinson's disease. Current Neurology and Neuroscience Reports 5(4): 261-262
Zanetti, R.; Rosso, S. 2007: Levodopa and the risk of melanoma. Lancet 369(9558): 257-258
Hensman, D.J.; Bain, P.G. 2006: Levodopa can worsen tremor associated with dystonia. Movement Disorders: Official Journal of the Movement Disorder Society 21(10): 1778-1780
Kumakura, Y.; Danielsen, E.H.; Reilhac, A.; Gjedde, A.; Cumming, P. 2004: Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurologica Scandinavica 110(3): 188-195
Nova, I.C.; Perracini, M.ôn.R.; Ferraz, H.B. 2004: Levodopa effect upon functional balance of Parkinson's disease patients. Parkinsonism and Related Disorders 10(7): 411-415
O'Suilleabhain, P.; Diaz-Arrastia, R. 2004: Levodopa elevates homocysteine: is this a problem?. Archives of Neurology 61(5): 633-634
Juri C, C.; Chaná C, P. 2006: Levodopa for Parkinson's disease: what have we learned?. Revista Medica de Chile 134(7): 893-901
Yamauchi, K.; Takehisa, M.; Tsuno, M.; Kaneda, Y.; Taniguchi, T.; Ohno, H.; Sei, H.; Morita, Y.; Ohmori, T. 2003: Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease. General Hospital Psychiatry 25(2): 140-142
Lou, J.-S.; Kearns, G.; Benice, T.; Oken, B.; Sexton, G.; Nutt, J. 2003: Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Movement Disorders: Official Journal of the Movement Disorder Society 18(10): 1108-1114
Gerlach, M.; Reichmann, H.; Riederer, P. 2005: Levodopa in the treatment of Parkinson's disease: current controversies. Movement disorders: official journal of the Movement Disorder Society 20(5): 643; author reply 643-4
Wilcox, R.A.; Churchyard, A.; Dahl, H.H.; Hutchison, W.M.; Kirby, D.M.; Thyagarajan, D. 2007: Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions. Movement Disorders: Official Journal of the Movement Disorder Society 22(7): 1020-1023
Mohr, C.; Landis, T.; Bracha, H.S.; Fathi, M.; Brugger, P. 2005: Levodopa reverses gait asymmetries related to anhedonia and magical ideation. European Archives of Psychiatry and Clinical Neuroscience 255(1): 33-39
Kupsch, A.; Trottenberg, T.; Bremen, D. 2004: Levodopa therapy with entacapone in daily clinical practice: results of a post-marketing surveillance study. Current Medical Research and Opinion 20(1): 115-120
Happe, S.; Tings, T.; Helmschmied, K.; Neubert, K.; Wuttke, W.; Paulus, W.; Trenkwalder, C. 2004: Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 19(12): 1511-1515
Matsuda, W.; Komatsu, Y.; Yanaka, K.; Matsumura, A. 2005: Levodopa treatment for patients in persistent vegetative or minimally conscious states. Neuropsychological Rehabilitation 15(3-4): 414-427
Müller, T.; Russ, H. 2006: Levodopa, motor fluctuations and dyskinesia in Parkinson's disease. Expert Opinion on PharmacoTherapy 7(13): 1715-1730
Kumar, N.; Van Gerpen, J.A.; Bower, J.H.; Ahlskog, J.E. 2005: Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Movement Disorders: Official Journal of the Movement Disorder Society 20(3): 342-344
De Letter, M.; Santens, P.; De Bodt, M.; Boon, P.; Van Borsel, J. 2006: Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgica 106(1): 19-22
Nicholas, A.P. 2007: Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Movement Disorders: Official Journal of the Movement Disorder Society 22(1): 99-104
Tan, E.K.; Chan, L.L.; Wong, M.C. 2003: Levodopa-induced oromandibular dystonia in progressive supranuclear palsy. Clinical Neurology and Neurosurgery 105(2): 132-134
Seppi, K.; Högl, B.; Diem, A.; Peralta, C.; Wenning, G.K.; Poewe, W. 2006: Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy. Movement Disorders: Official Journal of the Movement Disorder Society 21(8): 1281-1283
Diepold, K.; Schütz, B.; Rostasy, K.; Wilken, B.; Hougaard, P.; Güttler, F.; Romstad, A.; Birk Møller, L. 2005: Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections. Movement Disorders: Official Journal of the Movement Disorder Society 20(6): 764-767
Kim, M.J.; Chung, S.J.; Sung, Y.H.; Lee, M.C.; Im, J.-H. 2006: Levodopa-responsive parkinsonism associated with hydrocephalus. Movement Disorders: Official Journal of the Movement Disorder Society 21(8): 1279-1281
Kang, S.Y.; Lee, M.H.; Lee, S.K.; Sohn, Y.H. 2004: Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. Parkinsonism and Related Disorders 10(7): 425-427
Kivi, A.; Trottenberg, T.; Kupsch, A.; Plotkin, M.; Felix, R.; Niehaus, L. 2005: Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra. Movement Disorders: Official Journal of the Movement Disorder Society 20(2): 258-260
Padeĭskaia, E.N. 2004: Levofloxacin (Tavanic) and therapy of urogenital infections. Antibiotiki i Khimioterapiia 49(6): 30-39
Maĭchuk, I.F. 2003: Levofloxacin (Tavanic) in the treatment of corneal ulcers. Antibiotiki i Khimioterapiia 48(6): 16-19
Gedeon, P.C.; Schaller, T.H.; Chitneni, S.K.; Choi, B.D.; Kuan, C.-T.; Suryadevara, C.M.; Snyder, D.J.; Schmittling, R.J.; Szafranski, S.E.; Cui, X.; Healy, P.N.; Herndon, J.E.; McLendon, R.E.; Keir, S.T.; Archer, G.E.; Reap, E.A.; Sanchez-Perez, L.; Bigner, D.D.; Sampson, J.H. 2018: A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 24(15): 3611-3631
Shorr, A.F.; Khashab, M.M.; Xiang, J.X.; Tennenberg, A.M.; Kahn, J.B. 2006: Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients. Respiratory Medicine 100(12): 2129-2136
Gutiérrez, E.; Morales, E.; García Rubiales, M.A.; Valentín, M.O. 2003: Levofloxacin and Achilles tendon involvement in hemodialysis patients. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 23(6): 558-559
Kraus, C.N.; Zalkikar, J.; Powers, J.H. 2005: Levofloxacin and macrolides for treatment of Legionnaires disease: multiple comparisons give few answers. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 41(3): 416; author reply 416-7
Korzets, A.; Gafter, U.; Dicker, D.; Herman, M.; Ori, Y. 2006: Levofloxacin and rhabdomyolysis in a renal transplant patient. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 21(11): 3304-3305
Perry, A.C.; Prpa, B.; Rouse, M.S.; Piper, K.E.; Hanssen, A.D.; Steckelberg, J.M.; Patel, R. 2003: Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clinical Orthopaedics and Related Research 414: 95-100
Watanabe, Y.; Aoyama, N.; Shirasaka, D.; Maekawa, S.; Kuroda, K.; Miki, I.; Kachi, M.; Fukuda, M.; Wambura, C.; Tamura, T.; Kasuga, M. 2003: Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 35(10): 711-715
Morimoto, K.; Koh, M.; Kinoshita, H. 2002: Levofloxacin for prophylaxis in breast cancer surgery compared with ofloxacin. Japanese Journal of Antibiotics 55(6): 866-874
Lynch, J.P.; File, T.M.; Zhanel, G.G. 2006: Levofloxacin for the treatment of community-acquired pneumonia. Expert Review of AntI-Infective Therapy 4(5): 725-742
Moine, P.; Bédos, J-Pierre. 2005: Levofloxacin for treatment of ventilator-associated pneumonia: putting the cart before the horse. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 41(3): 414-5; author reply 415-6
Kadam, G.S.; Naikwadi, A.; Rao, S.K.S.; Sawardekar, S.S.; Gawde, A.; Baliga, V.; Desai, A. 2005: Levofloxacin in enteric fever--a study. Journal of the Indian Medical Association 103(8): 441
Alvarez Lerma, F.; Palomar, M.; Olaechea, P.; Leon, C.; Sanchez, M.; Bermejo, B. 2004: Levofloxacin in patients in the ICU. Factors influencing the choice of dose and its use in combined therapy. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 17(1): 57-63
Gehanno, P.; Pessey, J.-J.; Serrano, E. 2005: Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications. Medecine et Maladies Infectieuses 35(6): 335-343
Alvarez-Lerma, F.; Grau, S.; Alvarez-Beltrán, M. 2006: Levofloxacin in the treatment of ventilator-associated pneumonia. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 12(Suppl 3): 81-92
Gunduz, A.; Turedi, S.; Kalkan, A.; Nuhoglu, I. 2006: Levofloxacin induced myasthenia crisis. Emergency Medicine Journal: Emj 23(8): 662
Sidirenko, S.V. 2006: Levofloxacin nowadays. Antibiotiki i Khimioterapiia 51(1): 28-37
Hiyama, L.; Tang, A.; Miller, L.G. 2006: Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 47(1): E9-13
Sowinski, K.M.; Lucksiri, A.; Kays, M.B.; Scott, M.K.; Mueller, B.A.; Hamburger, R.J. 2003: Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 42(2): 342-349
Tattersall, M. 2006: Levofloxacin prevented fever and infection during prolonged chemotherapy-induced neutropenia. Acp Journal Club 144(2): 40
Bastida, T.; Pérez-Vázquez, M.ía.; Campos, J.é; Cortés-Lletget, M.ía.C.; Román, F.; Tubau, F.; de la Campa, A.G.; Alonso-Tarrés, C. 2003: Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerging Infectious Diseases 9(11): 1475-1478
Geijo Martínez, M.P.; Díaz de Tuesta Chow-Quan, A.M.; Herranz, C.R.; Gómez Criado, C.; Dimas Nuñez, J.F.; Saiz García, F. 2002: Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization. Anales de Medicina Interna 19(12): 621-625
Timmers, G.J.; Simoons-Smit, A.M.; Leidekker, M.E.; Janssen, J.J.W.M.; Vandenbroucke-Grauls, C.M.J.E.; Huijgens, P.C. 2007: Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 13(5): 497-503
Matsumoto, Y.; Miki, I.; Aoyama, N.; Shirasaka, D.; Watanabe, Y.; Morita, Y.; Toyoda, M.; Mitani, T.; Miyachi, H.; Tamura, T.; Kasuga, M. 2005: Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 37(11): 821-825
Gisbert, J.P.; Gisbert, J.Luis.; Marcos, S.; Moreno-Otero, R.; Pajares, J.Maria. 2007: Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Helicobacter 12(1): 68-73
Kang, M.S.; Park, D.I.; Yun, J.W.; Oh, S.Y.; Yoo, T.W.; Park, J.H.; Kim, H.J.; Cho, Y.K.; Sohn, C.I.; Jeon, W.K.; Kim, B.I. 2006: Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication. Korean Journal of Gastroenterology 47(1): 30-36
Yuan, Y.; Thabane, L.; Hunt, R.H. 2006: Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence?. Alimentary Pharmacology and Therapeutics 23(8): 1283-5; Author Reply 1285-6
Chan, F.K.L. 2004: Levofloxacin-based triple regimens were better than standard quadruple regimens for second-line eradication of Helicobacter pylori. Acp Journal Club 141(1): 19
Sugimoto, T.; Kaneko, H.; Deji, N.; Koya, D. 2005: Levofloxacin-induced Achilles tendon rupture in a patient with systemic microscopic polyangiitis. Modern Rheumatology 15(3): 217-219
Kowatari, K.; Nakashima, K.; Ono, A.; Yoshihara, M.; Amano, M.; Toh, S. 2004: Levofloxacin-induced bilateral Achilles tendon rupture: a case report and review of the literature. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 9(2): 186-190
Filippucci, E.; Farina, A.; Bartolucci, F.; Spallacci, C.; Busilacchi, P.; Grassi, W. 2003: Levofloxacin-induced bilateral rupture of the Achilles tendon: clinical and sonographic findings. Reumatismo 55(4): 267-269
Fernández-Torre, J.é L. 2006: Levofloxacin-induced delirium: Diagnostic considerations. Clinical Neurology and Neurosurgery 108(6): 614
Islam, A.F.M.S.; Rahman, M.S. 2005: Levofloxacin-induced fatal toxic epidermal necrolysis. Annals of PharmacoTherapy 39(6): 1136-1137
Zaigraykin, N.; Kovalev, J.; Elias, N.; Naschitz, J.E. 2006: Levofloxacin-induced interstitial nephritis and vasculitis in an elderly woman. Israel Medical Association Journal: Imaj 8(10): 726-727
Sánchez Muñoz, L.A.; Sanjuán Portugal, F.J.; Naya Machado, J.; Castiella Herrero, J. 2006: Levofloxacin-induced tendon rupture with fatal outcome. Anales de Medicina Interna 23(2): 102
Gold, L.; Igra, H. 2003: Levofloxacin-induced tendon rupture: a case report and review of the literature. Journal of the American Board of Family Practice 16(5): 458-460
Bird, S.B.; Orr, P.G.; Mazzola, J.L.; Brush, D.E.; Boyer, E.W. 2005: Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factors. Journal of Clinical Psychopharmacology 25(3): 287-288
Azanza, J.R.; Cárdenas, E.; Muñóz, M.J.; Valentí, J.R.; García-Quetglas, E. 2002: Levofloxacin. Clinical experience with long-term treatment of osteoarticular infections. Revista de Medicina de la Universidad de Navarra 46(3): 23-27
Sinopal'nikov, A.I.; Romanovskiĭ, A.G. 2004: Levofloxacin: role and place in the treatment of infections of the lower respiratory tracts. Terapevticheskii Arkhiv 76(11): 51-56
Fish, D.N. 2003: Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'. Expert Review of Anti-Infective Therapy 1(3): 371-387
Bru, J.-P.; Leophonte, P.; Veyssier, P. 2003: Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis. Revue de Pneumologie Clinique 59(6): 348-356
Poore, M.W. 2002: Levoglucosan in PM2.5 at the Fresno supersite. Journal of the Air and Waste Management Association 52(1): 3-4
Ridanovic, S. 1961: Levomepromazin (nozinan, 7044 R. P.) in the treatment of mental disorders. Neuropsihijatrija 9: 63-76
Svenneby, G.; Kvamme, E.; Eitinger, L. 1965: Levomepromazine (Nozinan) Medication as a Source of Error in the Laboratory Diagnosis of Phenylketonuria. Scandinavian Journal of Clinical and Laboratory Investigation 17: 260-264
Juhlin, L.; Skogh, M. 1960: Levomepromazine (Nozinan): a new oral drug for the treatment of nocturnal itching. Svenska Lakartidningen 57: 3085-3093
Telatin, L.; Maccagnani, G. 1959: Levomepromazine (RP. 7044)-a new phenothiazine derivative-in psychiatric therapy (pharmacological notes, review of the literature and clinical contribution). Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali Suppl 83(2): 847-898
Anonymous 1961: Levomepromazine (maleate). Annales Pharmaceutiques Francaises 19: 459-461
Huot, J.M.; Kristof, A.C. 1959: Levomepromazine (nozinan)-a new neuroleptic agent for treatment of senile patients. Canadian Medical Association Journal 81: 546-548
Panaccio, V. 1964: Levomepromazine in the Treatment of Pruriginous Dermatoses. L'Union Medicale du Canada 93: 317-319
Alberton, G. 1959: Levomepromazine and the EEG picture. Preliminary note. Minerva Medica 50: 2501-2502
Cavalli, A.; Coletti, G.; Fabiani, A. 1960: Levomepromazine by intravenous route in states of psychomotor agitation. Initial trials in psychiatric therapy. Minerva Medica 51: 3262-3266
Kleiman, F. 1961: Levomepromazine in anesthesiological practice. El Dia Medico 33: 1369-1372
Decourt, A. 1959: Levomepromazine in anesthesiology. Anesthesie Analgesie Reanimation 16: 808-819
Divry, P.; Bobon, J.; Collard, J. 1959: Levomepromazine in potentiated sleep therapy and neuroleptic cures. Acta Neurologica et Psychiatrica Belgica 59(3): 325-336
Darbon, A.; Portal, A. 1959: Levomepromazine in present-day medical use. Therapie 14: 811-817
Telatin, L. 1959: Levomepromazine in psychiatry. Minerva Medica 50(7): 166-169
Ferrari-Parabita, G. 1961: Levomepromazine in the medical treatment of essential neuralgia of the trigeminus. Minerva Anestesiologica 27: 318-322
Grassi, B. 1960: Levomepromazine in the treatment of mental disorders. Rassegna di Neuropsichiatria E Scienze Affini 15: 43-56
Payne, P.; Verinder, D. 1960: Levomepromazine in the treatment of neuroleptic-resistant psychotics. Journal of Mental Science 106: 1429-1431
Amini-Adle, M.; Ravel, A.-C.; Guillot, I.; Nicolas, J.-F. 2005: Levomepromazine-induced peripheral edema. Annales de Dermatologie et de Venereologie 132(1): 48
Samele Acquaviva, E.; Cucciniello, G. 1963: Levomepromazine: a new neuroleptic in the immediate postoperative period. Acta Anaesthesiologica 14: 95-104
Artem'ev, S.A.; Niunikova, O.I.; Zharov, A.V.; Metal'nikov, B.P.; Kislova, T.A.; Starostina, Z.D.; Chastikova, A.V.; Temianko, S.A.; Ikonnikov, N.N.; Aralova, E.T.; Grishina, Z.M. 1959: Levomycetin in the treatment of gonorrhea; result of complex work. Vestnik Dermatologii i Venerologii 33(2): 70-73
Gubaidullina, M.Z. 1961: Levomycetin therapy of Staphylococcus and Proteus wound infections in rabbits immunized with staphylococcal anatoxin. Antibiotiki 6: 1096-1100
Vorotyntseva, N.V. 1952: Levomycetin therapy of dysentery in children. Pediatriia 3: 50-58
Benagiano, A. 1955: Levomycin in dental therapy. Rivista Italiana di Stomatologia 10(3): 205-211
Simbiriakova, K.I. 1958: Levomycin therapy of chronic cholecystoangiocholitis. Terapevticheskii Arkhiv 30(10): 49-52
Anonymous 2005: Levonorgestrel. Nursing Times 101(2): 31
Sarkar, N.N. 2003: Levonorgestrel as an emergency contraceptive drug. International Journal of Clinical Practice 57(9): 824-828
Kailasam, C.; Akande, V.; Gordon, U.D. 2005: Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report. Journal of Assisted Reproduction and Genetics 22(3): 137-140
Sturdee, D. 2006: Levonorgestrel intrauterine system for endometrial protection. Journal of the British Menopause Society 12(Suppl 1): 1-3
Martínez-Zamora, M.A.; Bellart, J.; Coll, O.; Balasch, J. 2005: Levonorgestrel postcoital contraception: a sociodemographic study. Medicina Clinica 125(2): 75-76
Boutet, G. 2006: Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?. Gynecologie Obstetrique and Fertilite 34(11): 1015-1023
Bahamondes, L.; Ribeiro-Huguet, P.; de Andrade, K.C.; Leon-Martins, O.; Petta, C.A. 2003: Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstetricia et Gynecologica Scandinavica 82(6): 580-582
Peled, Y.; Perri, T.; Pardo, Y.; Kaplan, B. 2007: Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review. Menopause 14(3 Part 1): 550-554
Radesic, B.; Sharma, A. 2004: Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Australian and New Zealand Journal of Obstetrics and Gynaecology 44(3): 247-251
Sheng, J.; Lu, D.; Zhang, J.-p.; Cui, G.-f. 2006: Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis. Zhonghua Fu Chan Ke Za Zhi 41(7): 467-470
Yazbeck, C.; Omnes, S.; Vacher-Lavenu, M.-C.; Madelenat, P. 2006: Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: a French multicenter study. Gynecologie Obstetrique and Fertilite 34(10): 906-913
Hurskainen, R.; Paavonen, J. 2004: Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Current Opinion in Obstetrics and Gynecology 16(6): 487-490
Hurskainen, R.; Teperi, J.; Aalto, A.-M.; Grenman, S.; Kivelä, A.; Kujansuu, E.; Vuorma, S.; Yliskoski, M.; Rissanen, P.; Paavonen, J. 2004: Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome. Acta Obstetricia et Gynecologica Scandinavica 83(4): 401-403
Gupta, B.; Mittal, S.; Misra, R.; Deka, D.; Dadhwal, V. 2006: Levonorgestrel-releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 95(3): 261-266
Pacheco del Cerro, E.; Torrijos Guerra, A.M.; Meneses Monroy, A.; Ramos Sánchez, L.M.ía.; Domínguez Peinado, B. 2003: Levonorgestrel. the day-after pill. Revista de Enfermeria 26(9): 31-34
Gervais, N. 1958: Levophed. Canadian Nurse 54(10): 938 Passim
Tainter, M.L. 1955: Levophed in coronary occlusion. Boletin de la Asociacion Medica de Puerto Rico 47(8): 305-322
Paradis, B.; Plante, G.; Aubut, J.; Tardif, A. 1959: Levopromasine (nozinan or RP 7044). Clinical, pharmacological and biochemical study based on 1000 cases. Laval Medical 28: 433-447
Thiebaut, F.; Heimendinger, E.; Philippides, D.; Israel, L. 1953: Levorotary ophthalmoplegia in left cerebellar abscess caused by otitis. Revue d'Oto-Neuro-Ophtalmologie 25(7): 442-444
Brown, A.K. 1954: Levorphan in anaesthesia. British Medical Journal 2(4894): 967-969
Prommer, E. 2007: Levorphanol: the forgotten opioid. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 15(3): 259-264
Milgrom, H. 2006: Levosalbutamol in the treatment of asthma. Expert Opinion on PharmacoTherapy 7(12): 1659-1668
Coopersmith, C.M. 2005: Levosimendan and gut mucosal blood flow--not all inotropes are created equal. Critical Care Medicine 33(1): 246-247
McLachlan, C.S.; Mossop, P. 2006: Levosimendan and plasma BNP levels: do inflammatory cytokines regulate BNP in chronic decompensated heart failure?. European journal of heart failure 8(2): 216-7; author reply 218
Berger, R.; Moertl, D.; Huelsmann, M.; Bojic, A.; Ahmadi, R.; Heissenberger, I.; Pacher, R. 2007: Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure. European Journal of Heart Failure 9(2): 202-208
Delange Segura, L.; Jerez Anera, M.; Carmona Aurioles, J.; Rodríguez Fernández, S. 2003: Levosimendan as inotropic support during coronary surgery with extracorporeal circulation in a patient with severely depressed ventricular function. Revista Espanola de Anestesiologia y Reanimacion 50(8): 423-424
Nieminen, M.S. 2003: Levosimendan compared with dobutamine in low output patients. Minerva Anestesiologica 69(4): 258-263
Raftopoulos, S.C. 2004: Levosimendan following coronary artery bypass grafting in a patient with end-stage renal failure: a case report. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine 6(2): 109-112
Egan, J.R.; Clarke, A.J.B.; Williams, S.; Cole, A.D.; Ayer, J.; Jacobe, S.; Chard, R.B.; Winlaw, D.S. 2006: Levosimendan for low cardiac output: a pediatric experience. Journal of Intensive Care Medicine 21(3): 183-187
Nguyen, H.D.; McKeown, B. 2005: Levosimendan for post-partum cardiomyopathy. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine 7(2): 107-110
Parissis, J.T.; Filippatos, G.; Farmakis, D.; Adamopoulos, S.; Paraskevaidis, I.; Kremastinos, D. 2005: Levosimendan for the treatment of acute heart failure syndromes. Expert Opinion on PharmacoTherapy 6(15): 2741-2751
Parissis, J.T.; Farmakis, D.; Bistola, V.; Adamopoulos, S.; Kremastinos, D.T. 2007: Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients. American Journal of Cardiology 99(1): 146-147
Akgul, A.; Mavioglu, L.; Katircioglu, S.F.; Pac, M.; Cobanoglu, A. 2006: Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting. Heart Lung and Circulation 15(5): 320-324
Tachibana, H.; Cheng, H.-J.; Ukai, T.; Igawa, A.; Zhang, Z.-S.; Little, W.C.; Cheng, C.-P. 2005: Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure. American Journal of Physiology. Heart and Circulatory Physiology 288(2): H914-H922
Cammarata, G.A.A.M.; Weil, M.Harry.; Sun, S.; Huang, L.; Fang, X.; Tang, W. 2006: Levosimendan improves cardiopulmonary resuscitation and survival by K(ATP) channel activation. Journal of the American College of Cardiology 47(5): 1083-1085
Huang, L.; Weil, M.Harry.; Sun, S.; Cammarata, G.; Cao, L.; Tang, W. 2005: Levosimendan improves postresuscitation outcomes in a rat model of CPR. Journal of Laboratory and Clinical Medicine 146(5): 256-261
Missant, C.; Rex, S.; Segers, P.; Wouters, P.F. 2007: Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Critical Care Medicine 35(3): 707-715
Garcia, J.é A.P.; Simvoulidis, L.F.N.; Salluh, J.I.F.; Hansen, M.H.A.; Feres, G.A.; Holanda, G.S.; Souza, R.C.S.; Toscano, L.; Soares, M.ár. 2007: Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity. International Journal of Cardiology 118(3): 406-407
Delgado, J.F. 2006: Levosimendan in acute heart failure: past, present and future. Revista Espanola de Cardiologia 59(4): 309-312
Siirilä-Waris, K.; Suojaranta-Ylinen, R.; Harjola, V.-P. 2005: Levosimendan in cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 19(3): 345-349
Raja, S.G.; Rayen, B.S. 2006: Levosimendan in cardiac surgery: current best available evidence. Annals of Thoracic Surgery 81(4): 1536-1546
Cardoso, J.S.; Ferreira, J.; de Sá, E.P.; de Campos, J.M.; Fonseca, C.ân.; Lousada, N.; Moreira, J.I.íd.; Rabaçal, C.; Damasceno, A.; Seabra-Gomes, R.; Ferreira, R.; Abreu e Lima, C. 2004: Levosimendan in daily intensive care practice--the experience of 15 centers. Background, methods and organization of the PORTLAND study. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(11): 1431-1443
Scelsi, L.; Campana, C.; Ghio, S.; Monti, L.; Opasich, C.; De Feo, S.; Cobelli, F.; Orlandi, M.; Di Pasquale, G.; Tavazzi, L. 2004: Levosimendan in heart failure. Recenti Progressi in Medicina 95(7-8): 376-383
García Graullera, R.d.J.ús.; Sánchez Mécatl, M.A.; Cerda García, P.; Torreblanca Marín, M.; Aguirre Sánchez, J.S.; Martínez Sánchez, J.ús. 2005: Levosimendan in patients with acute cardiac failure. Archivos de Cardiologia de Mexico 75(Suppl 3): S3
Lehmann, A.; Lang, J.; Boldt, J.; Isgro, F.; Kiessling, A.H. 2004: Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 10(8): Mt89-Mt93
Follath, F. 2003: Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(Suppl 2): 34s-38s
Pieske, B. 2002: Levosimendan in regional myocardial ischemia. Cardiovascular Drugs and Therapy 16(5): 379-381
Noto, A.; Giacomini, M.; Palandi, A.; Stabile, L.; Reali-Forster, C.; Iapichino, G. 2005: Levosimendan in septic cardiac failure. Intensive Care Medicine 31(1): 164-165
De Backer, D.; Taccone, F.Silvio.; Radermacher, P. 2007: Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking. Intensive Care Medicine 33(3): 403-405
Morais, R.J. 2006: Levosimendan in severe right ventricular failure following mitral valve replacement. Journal of Cardiothoracic and Vascular Anesthesia 20(1): 82-84
Schwarte, L.A.; Picker, O.; Bornstein, S.R.; Fournell, A.; Scheeren, T.W.L. 2005: Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Critical Care Medicine 33(1): 135-142; Discussion: 246-247
Braun, J-Peter.; Jasulaitis, D.; Moshirzadeh, M.; Doepfmer, U.R.; Kastrup, M.; von Heymann, C.; Dohmen, P.M.; Konertz, W.; Spies, C. 2006: Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure. Critical Care 10(1): R17
Al-Shawaf, E.; Ayed, A.; Vislocky, I.; Radomir, B.; Dehrab, N.; Tarazi, R. 2006: Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. Journal of Cardiothoracic and Vascular Anesthesia 20(3): 353-357
Mueller, T.; Gegenhuber, A.; Haltmayer, M. 2005: Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failure. International journal of cardiology 104(3): 355-6; author reply 357-8
Petäjä, L.M.; Sipponen, J.T.; Hämmäinen, P.J.; Eriksson, H.I.; Salmenperä, M.T.; Suojaranta-Ylinen, R.T. 2006: Levosimendan reversing low output syndrome after heart transplantation. Annals of Thoracic Surgery 82(4): 1529-1531
Parissis, J.T.; Farmakis, D.; Kremastinos, D.T. 2006: Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?. European Journal of Heart Failure 8(2): 215; Author Reply 218
Ng, T.M.H. 2004: Levosimendan, a new calcium-sensitizing inotrope for heart failure. PharmacoTherapy 24(10): 1366-1384
Bonnefoy, E.; Trindade, P.T. 2005: Levosimendan, a revolution in the world of inotropic agents?. Revue Medicale Suisse 1(21): 1425-1426; 1428-1429
Rasmussen, T.; Schmidt, H. 2006: Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?. Ugeskrift for Laeger 168(3): 261-265
Luther, Y.C.; Schulze-Neick, I.; Stiller, B.; Ewert, P.; Redlin, M.; Nasseri, B.; Mühler, E.G.; Hetzer, R.; Lange, P.E. 2004: Levosimendan-long-term inodilation in an infant with myocardial infarction. Zeitschrift für Kardiologie 93(3): 234-239
Lehtonen, L. 2004: Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure. Current Heart Failure Reports 1(3): 136-144
Morais, Jão.; Dias, B.; Pontes, N. 2003: Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(7-8): 941-948
Mebazaa, A.; Erhardt, L. 2003: Levosimendan: a new dual-action drug in the treatment of acute heart failure. International Journal of Clinical Practice 57(5): 410-416
Kivikko, M.; Lehtonen, L. 2005: Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure. Current Pharmaceutical Design 11(4): 435-455
Holley, A.D.; Ziegenfuss, M. 2006: Levosimendan: a new option in acute cardiac failure. Emergency Medicine Australasia: Ema 18(5-6): 505-509
Del-Razo, O.E.; Carballal-Sanjurjo, J.C.; Campos Lara, M.ía.G.; Palma-Aguirre, J.é A. 2003: Levosimendan: a new option in the pharmacologic management of cardiac insufficiency. Gaceta Medica de Mexico 139(1): 87-89
González-Chon, O.; García López, S.M.ía.d.C.; Chacón Mercado, M.A.; Arias Sánchez, E.A.ín.; Vega Zapata, R.E. 2005: Levosimendan: a new strategy in the treatment of heart failure. Archivos de Cardiologia de Mexico 75(Suppl 3): S3
Ellger, B.M.; Zahn, P.K.; Van Aken, H.K.; Schmidt, C.; Brussel, T. 2006: Levosimendan: a promising treatment for myocardial stunning?. Anaesthesia 61(1): 61-63
Ng, T.M.H.; Akhter, M.W. 2005: Levosimendan: dual mechanisms for acute heart failure...and beyond?. Minerva Cardioangiologica 53(6): 565-584
Cleland, J.G.F.; Nikitin, N.; McGowan, J. 2004: Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Expert Review of Cardiovascular Therapy 2(1): 9-19
Agewall, S.; Atar, D. 2007: Levosimendan: perpetuum mobile?. European Heart Journal 28(4): 515
Mearin, F.ín.; Rodrigo, L.; Pérez-Mota, A.; Balboa, A.ín.; Jiménez, I.; Sebastián, J.J.é; Patón, C. 2004: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 2(4): 301-308
Alzoubi, K.H.; Gerges, N.Z.; Alkadhi, K.A. 2005: Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Experimental Neurology 195(2): 330-341
Hennessey, J.V. 2003: Levothyroxine a new drug? Since when? how could that be?. Thyroid: Official Journal of the American Thyroid Association 13(3): 279-282
Bongiovanni, M.N.; Aprile, F.A.; Sormanni, P.; Vendruscolo, M. 2018: A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet β-Cells. International Journal of Molecular Sciences 19(5)
Nugent, J.S.; Nugent, A.L.; Whisman, B.A.; White, K.; Hagan, L.L. 2003: Levothyroxine anaphylaxis? Vocal cord dysfunction mimicking an anaphylactic drug reaction. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 91(4): 337-341
Fox, G.N. 2005: Levothyroxine and FDA bioequivalence ratings. Journal of Family Practice 54(2): 179
Neafsey, P.J. 2004: Levothyroxine and calcium interaction: timing is everything. Home Healthcare Nurse 22(5): 338-339
De Luis, D.A.; Abad, L.; Aller, R.; González-Sagrado, M.; Dueñas, A. 2004: Levothyroxine poisoning: clinical manifestations and therapeutic management. Anales de Medicina Interna 21(1): 39-41
Verhaert, N.; Vander Poorten, V.; Delaere, P.; Bex, M.; Debruyne, F. 2006: Levothyroxine replacement therapy after thyroid surgery. B-Ent 2(3): 129-133
Fadeyev, V.V.; Sytch, J.; Kalashnikov, V.; Rojtman, A.; Syrkin, A.; Melnichenko, G. 2006: Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 12(1): 5-17
Wartofsky, L. 2005: Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration?. Archives of Internal Medicine 165(15): 1683-1684
Salomon, R.G. 2005: Levuglandins and isolevuglandins: stealthy toxins of oxidative injury. Antioxidants and Redox Signaling 7(1-2): 185-201
Jorde, W.O. 1953: Levulose and creatine metabolism. Zeitschrift für die Gesamte Experimentelle Medizin 121(2): 170-180
Duran Quevedo, T. 1957: Levulose in metabolism of glucides. Revista Cubana de Pediatria 29(8): 415-444
Lasch, F. 1950: Levulose in parenchymous liver disease; value of continuous treatment with high dosage, with special reference to the liver function test. Klinische Medizin; Osterreichische Zeitschrift für Wissenschaftliche und Praktische Medizin 5(5): 212-220
Duran Quevedo, T. 1958: Levulose in the treatment of diabetes. Revista Clinica Espanola 70(2): 93-97
Izar, G. 1959: Levulose in therapy of diabetes and cardiovascular diseases. Rassegna Clinico-Scientifica 35(3): 65-67
Siedek, H.; Myslivec, O. 1950: Levulose therapy. Schweizerische Medizinische Wochenschrift 80(16): 413-416
Hiller, J. 1955: Levulose utilization in acidotic diabetes mellitus. I. Analysis of acetonuria and glucosuria. Zeitschrift für Klinische Medizin 153(4): 388-396
Hiller, J. 1955: Levulose utilization in acidotic diabetes mellitus. II. Blood-chemical analysis. Zeitschrift für Klinische Medizin 153(4): 397-406
Martin, M.A. 1962: Levulose utilized in intolerance to antibiotics and antitubercular agents. Therapeutische Umschau. Revue Therapeutique 19: 58-61
Bezjak, V. 1953: Levuriform fungi isolated from patients in Zagreb. Radovi Medicinskog Faculteta U Zagrebu 1: 107-111
Barzizza, C.M.; Ricardi, E.A. 1955: Levuriform phase of Histoplasma duboisii-Vanbreuseghem 1952. Prensa Medica Argentina 42(35): 2706-2708
De Souza, A.R. 1953: Lewandowsky and Lutz's epidermodysplasia verruciformis. Revista Paulista de Medicina 42(6): 447-449
Costa, O.G. 1952: Lewandowsky nevus elasticus. Anais Brasileiros de Dermatologia E Sifilografia 27(3): 105-106
Jaquetidel Pozo 1964: Lewandowsky's Epidermodysplasia Verruciformias with Epithelial Degeneration. Actas Dermo-Sifiliograficas 55: 429-432
Snapp, R.H. 1949: Lewandowsky's rosacea-like eruption; a clinical study. Journal of Investigative Dermatology 13(4): 175-190
Lissia, G. 1955: Lewandowsky's rosacea-like tuberculid. Atti Della Societa Italiana di Dermatologia e Sifilografia e Delle Sezioni Interprovinciali. Societa Italiana di Dermatologia e Sifilografia 1: 31-35
Van Ketel, W.G. 1957: Lewandowsky's rosacea-like tuberculids. Nederlands Tijdschrift Voor Geneeskunde 101(42): 1987
Relias, A.; Sakellariou, G. 1964: Lewandowsky-Lutz Verruciform Epidermodysplasia. Annales de Dermatologie et de Syphiligraphie 91: 279-283
Duperrat, B.; Guilaine, J.; Laugier, A. 1959: Lewandowsky-Lutz epidermodysplasia verruciformis with epitheliomatous transformation. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 5: 687-690
Vorob'ev, I.I.; Kritskii, A.A. 1962: Lewered radiation doses in intra-oral roentgenography. Vestnik Rentgenologii i Radiologii 37: 63-64
Layani, F.; Chaouat, Y.; May, V. 1950: Lewin and Wassen method; 21 cases of inflammatory polyarthritis treated without results. Revue du Rhumatisme et des Maladies Osteo-Articulaires 17(7): 371-373
Anonymous 2004: Lewin estimate of Kerry health plan doubles campaign's fiqure. Medicine and Health 58(35): 3-4
Barr, D.P.; Conner, L.ATTERBURY. 1951: Lewis A. Conner, 1866-1950. Transactions of the Association of American Physicians 64: 8-9
Bowman, R.K.; Johnson, J.S. 2004: Lewis Acid catalyzed dipolar cycloadditions of an activated imidate. Journal of Organic Chemistry 69(24): 8537-8540
Zhao, Y.-J.; Chng, S.-S.; Loh, T.-P. 2007: Lewis Acid-promoted intermolecular acetal-initiated cationic polyene cyclizations. Journal of the American Chemical Society 129(3): 492-493
Barr, D.P. 1951: Lewis Atterbury Conner, 1867-1950. Circulation 3(2): 163
Wiener, A.S. 1965: Lewis Blood Types: Theoretical Implications and Practical Applications. American Journal of Clinical Pathology 43: 388-392
Salto-Tellez, M. 2005: Lewis Carroll versus George Papanicolaou: a case for a unified international classification of cervical cytology. Cytopathology: Official Journal of the British Society for Clinical Cytology 16(3): 153-155
Iles, A.E.; Thomson, L.C. 1955: Lewis Charles Thomson. British Journal of Ophthalmology 39(11): 703-704
Morrison, L.FRANCIS. 1957: Lewis Francis Morrison; 1899-1956. Transactions of the .. Annual Meeting of the American Laryngological Association. American Laryngological Association. Annual Meeting 78: 120-121
Glover, L.G. 1953: Lewis G. Glover. British Medical Journal 2(4840): 833-834
Andresen, A.F.; Cole, L.Gregory. 1955: Lewis Gregory Cole, 1874-1954. Gastroenterology 28(5): 867-871
Patchett, A.A.; Sarett, L.Hastings. 2002: Lewis Hastings Sarett, December 22, 1917 - November 29, 1999. Biographical Memoirs. National Academy of Sciences 81: 278-292
Weed, L.HILL. 1953: Lewis Hill Weed. Journal of the American Medical Association 151(5): 400
Fulton, J.F.; Weed, L.HILL. 1952: Lewis Hill Weed, 1886-1952. Yale journal of biology and medicine 25(3): 215-217
Boshes, B.; Pollock, L.J. 1952: Lewis J. Pollock. Quarterly Bulletin. Northwestern University . Medical School 26(1): 87-88
Rhoades, M.M.; Stadler, L.J. 1954: Lewis J. Stadeler, geneticist. Science 120(3119): 553-554
Waring, J.J.; Moorman, L.JEFFERSON. 1954: Lewis Jefferson Moorman. Transactions of the American Clinical and Climatological Association 66: Lxiv
Parks, J.; Sweet, L. 1950: Lewis Kaigler Sweet, A.B., M.D. (1902-1950). Medical annals of the District of Columbia 19(12): 722-723
Hilgard, E.R.; Terman, L.M. 1957: Lewis Madison Terman: 1877-1956. American journal of psychology 70(3): 472-479
Weissmann, G.; Thomas, L. 2003: Lewis Thomas (1913-1993). The element of style. Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 66(4): 4-10
Stapleton, D.H.; Hackett, L.W. 2005: Lewis W. Hackett and the early years of the International Health Board's Yellow Fever Program in Brazil, 1917-1924. Parassitologia 47(3-4): 353-360
Raffaele, G.; Hackett, L.W. 1962: Lewis Wendell HACKETT. Rivista di Malariologia 41: 243-244
Wolpert, L.; Wolpert, L. 2003: Lewis Wolpert. Current Biology: Cb 13(4): R120
Moyer, J.E. 1964: Lewis Yz: Microbiologic Studies of the Two-Man Space Cabin Simulator. Interchange of Oral and Intestinal Bacteria. Techn Docum Rep No. Sam-Tdr-64-3. Amd-Tr Reports . United States. Aerospace Medical Division 1964: 1-11
Heston, A.J.; Panzner, M.J.; Youngs, W.J.; Tessier, C.A. 2005: Lewis acid adducts of [PCl2N]3. Inorganic Chemistry 44(19): 6518-6520
Yang, Q.; Xiao, W.-J.; Yu, Z. 2005: Lewis acid assisted ring-closing metathesis of chiral diallylamines: an efficient approach to enantiopure pyrrolidine derivatives. Organic Letters 7(5): 871-874
Miranda, N.; Xu, L.; Newcomb, M. 2004: Lewis acid catalysis in heterolysis reactions of glycol ether radicals mimicking diol dehydratase-catalyzed reactions. Organic Letters 6(24): 4511-4514
Komoto, I.; Kobayashi, S.ū 2004: Lewis acid catalysis in supercritical carbon dioxide. use of poly(ethylene glycol) derivatives and perfluoroalkylbenzenes as surfactant molecules which enable efficient catalysis in ScCO2. Journal of Organic Chemistry 69(3): 680-688
Kennedy, J.W.J.; Hall, D.G. 2004: Lewis acid catalyzed allylboration: discovery, optimization, and application to the formation of stereogenic quaternary carbon centers. Journal of Organic Chemistry 69(13): 4412-4428
Palomo, C.; Oiarbide, M.; Arceo, E.; García, J.ús.M.; López, R.; González, A.; Linden, A. 2005: Lewis acid catalyzed asymmetric cycloadditions of nitrones: alpha'-hydroxy enones as efficient reaction partners. Angewandte Chemie 44(38): 6187-6190
Lu, J.-M.; Shi, M. 2006: Lewis acid catalyzed reaction of arylvinylidenecyclopropanes with acetals: a facile synthetic protocol for the preparation of indene derivatives. Organic Letters 8(23): 5317-5320
Shao, L.-X.; Zhang, Y.-P.; Qi, M.-H.; Shi, M. 2007: Lewis acid catalyzed rearrangement of vinylcyclopropenes for the construction of naphthalene and indene skeletons. Organic Letters 9(1): 117-120
Shi, M.; Jiang, M.; Liu, L.-P. 2007: Lewis acid catalyzed ring-opening reactions of methylenecyclopropanes with diphenylphosphine oxide in the presence of sulfur or selenium. Organic and Biomolecular Chemistry 5(3): 438-440
Renard, P.-Y.; Vayron, P.; Leclerc, E.; Valleix, A.; Mioskowski, C. 2003: Lewis acid catalyzed room-temperature Michaelis-Arbuzov rearrangement. Angewandte Chemie 42(21): 2389-2392
Huang, X.; Tang, E.; Xu, W.-M.; Cao, J. 2005: Lewis acid catalyzed solid-phase synthesis of flavonoids using selenium-bound resin. Journal of Combinatorial Chemistry 7(6): 802-805
Davies, H.M.L.; Dai, X. 2004: Lewis acid induced tandem Diels-Alder reaction/ring expansion as an equivalent of a [4 + 3] cycloaddition. Journal of the American Chemical Society 126(9): 2692-2693
Blid, J.; Brandt, P.; Somfai, P. 2004: Lewis acid mediated [2,3]-sigmatropic rearrangement of allylic alpha-amino amides. Journal of Organic Chemistry 69(9): 3043-3049
Blid, J.; Panknin, O.; Tuzina, P.; Somfai, P. 2007: Lewis acid mediated asymmetric [2,3]-sigmatropic rearrangement of allylic amines. Scope and mechanistic investigation. Journal of Organic Chemistry 72(4): 1294-1300
Patient, L.; Berry, M.B.; Coles, S.J.; Hursthouse, M.B.; Kilburn, J.D. 2003: Lewis acid mediated cyclisations of silylated methylenecyclopropyl hydrazones. Chemical Communications 20: 2552-2553
Rajamaki, S.; Kilburn, J.D. 2005: Lewis acid mediated endo-cyclisation of trimethylsilylmethylenecyclopropyl imines--a stereoselective route to indolizidines. Chemical Communications 12: 1637-1639
Kabalka, G.W.; Wu, Z.; Ju, Y.; Yao, M-Liang. 2005: Lewis acid mediated reactions of aldehydes with styrene derivatives: synthesis of 1,3-dihalo-1,3-diarylpropanes and 3-chloro-1,3-diarylpropanols. Journal of Organic Chemistry 70(25): 10285-10291
Yang, Y.-H.; Shi, M. 2005: Lewis acid mediated reactions of cyclopropyl aryl ketones with alpha-ketoesters: facile preparation of 5,6-dihydropyran-2-ones. Journal of Organic Chemistry 70(24): 10082-10085
Zhao, C.; Yan, J.; Xi, Z. 2003: Lewis acid mediated reactions of zirconacyclopentenes with aldehydes affording homoallyl ketones via oppenauer-type oxidation. Journal of Organic Chemistry 68(11): 4355-4360
Meyer, O.; Ponaire, S.; Rohmer, M.; Grosdemange-Billiard, C. 2006: Lewis acid mediated regioselective ring opening of benzylglycidol with dibenzyl phosphate: Short and attractive synthesis of dihydroxyacetone phosphate. Organic Letters 8(19): 4347-4350
Wang, F.; Xiao, Z.; Yao, Z.; Jia, Z.; Huang, S.; Gan, L.; Zhou, J.; Yuan, G.; Zhang, S. 2006: Lewis acid promoted preparation of isomerically pure fullerenols from fullerene peroxides C60(OOt-Bu)6 and C60(O)(OOt-Bu)6. Journal of Organic Chemistry 71(12): 4374-4382
Salter, M.H.; Reibenspies, J.H.; Jones, S.B.; Hancock, R.D. 2005: Lewis acid properties of zinc(II) in its cyclen complex. the structure of [Zn(cyclen)(S=C(NH2)2](ClO4)2 and the bonding of thiourea to metal ions. Some implications for zinc metalloenzymes. Inorganic Chemistry 44(8): 2791-2797
Gonsior, M.; Müller, L.; Krossing, I. 2006: Lewis acid stabilized OPI3: implications for the nature of free OPI3. Chemistry 12(22): 5815-5822
Gohier, F.éd.ér.; Bouhadjera, K.; Faye, D.; Gaulon, C.; Maisonneuve, V.; Dujardin, G.; Dhal, R. 2007: Lewis acid tuned facial stereodivergent HDA reactions using beta-substituted N-vinyloxazolidinones. Organic Letters 9(2): 211-214
Yamagiwa, N.; Qin, H.; Matsunaga, S.; Shibasaki, M. 2005: Lewis acid-Lewis acid heterobimetallic cooperative catalysis: mechanistic studies and application in enantioselective aza-Michael reaction. Journal of the American Chemical Society 127(38): 13419-13427
Tajima, Y.; Hara, T.; Honma, T.; Matsumoto, S.; Takeuchi, K. 2006: Lewis acid-assisted nucleophilic substitution of fullerene epoxide. Organic Letters 8(15): 3203-3205
Alves, W.A.; Antunes, O.A.C. 2007: Lewis acid-base adducts: a quantitative Raman analysis of formamide and dimethylsulfoxide mixtures. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 67(3-4): 847-851
Asao, N.; Aikawa, H. 2006: Lewis acid-catalyzed [4 + 2] benzannulation between enynal units and enols or enol ethers: novel synthetic tools for polysubstituted aromatic compounds including indole and benzofuran derivatives. Journal of Organic Chemistry 71(14): 5249-5253
Sáez, J.é A.; Arnó, M.; Domingo, L.R. 2003: Lewis acid-catalyzed [4 + 3] cycloaddition of 2-(trimethyl silyloxy)acrolein with furan. Insight on the nature of the mechanism from a DFT analysis. Organic Letters 5(22): 4117-4120
Asao, N.; Nogami, T.; Lee, S.; Yamamoto, Y. 2003: Lewis acid-catalyzed benzannulation via unprecedented [4+2] cycloaddition of o-alkynyl(oxo)benzenes and enynals with alkynes. Journal of the American Chemical Society 125(36): 10921-10925
Ishimaru, T.; Shibata, N.; Nagai, J.; Nakamura, S.; Toru, T.; Kanemasa, S. 2006: Lewis acid-catalyzed enantioselective hydroxylation reactions of oxindoles and beta-keto esters using DBFOX ligand. Journal of the American Chemical Society 128(51): 16488-16489
Smith, K.; Conley, N.; Hondrogiannis, G.; Glover, L.; Green, J.F.; Mamantov, A.; Pagni, R.M. 2004: Lewis acid-catalyzed rearrangement of 2,2-dichloronorbornane to 1-chloronorbornane. Journal of Organic Chemistry 69(14): 4843-4844
Xu, G.-C.; Liu, L.-P.; Lu, J.-M.; Shi, M. 2005: Lewis acid-catalyzed rearrangement of multi-substituted arylvinylidenecyclopropanes. Journal of the American Chemical Society 127(42): 14552-14553
Kim, M.S.; Kim, Y.-W.; Hahm, H.S.; Jang, J.W.; Lee, W.K.; Ha, H.-J. 2005: Lewis acid-catalyzed stereospecific ring expansion of aziridine-2-carboxylates to imidazolidin-2-ones. Chemical Communications 24: 3062-3064
Davies, H.M.L.; Dai, X. 2005: Lewis acid-catalyzed tandem Diels-Alder reaction/retro-Claisen rearrangement as an equivalent of the inverse electron demand hetero Diels-Alder reaction. Journal of Organic Chemistry 70(17): 6680-6684
Mizuta, S.; Shibata, N.; Ogawa, S.; Fujimoto, H.; Nakamura, S.; Toru, T. 2006: Lewis acid-catalyzed tri- and difluoromethylation reactions of aldehydes. Chemical Communications 24: 2575-2577
Lomberget, T.; Bentz, E.; Bouyssi, D.; Balme, G.èv. 2003: Lewis acid-induced intramolecular Friedel-Crafts cyclization of 1,3-bis-exocyclic dienes. a new route to 4a-methyltetrahydrofluorenes. Organic Letters 5(12): 2055-2057
Deak, H.L.; Williams, M.J.; Snapper, M.L. 2005: Lewis acid-mediated generation of bicyclo[5.3.0]decanes and bicyclo[4.3.0]nonanes. Organic Letters 7(26): 5785-5788
Reddy, D.S.; Judd, W.R.; Aubé, J. 2003: Lewis acid-mediated reactions of alkyl azides with alpha,beta-unsaturated ketones. Organic Letters 5(21): 3899-3902
Zhang, Y.; Shibatomi, K.; Yamamoto, H. 2004: Lewis acid-mediated selective chlorinations of silyl enolate. Journal of the American Chemical Society 126(46): 15038-15039
Hong, X.; Mejía-Oneto, J.é M.; Padwa, A. 2006: Lewis acid-promoted alpha-hydroxy beta-dicarbonyl to alpha-ketol ester rearrangement. Tetrahedron Letters 47(47): 8387-8390
Nair, V.; Dhanya, R.; Rajesh, C.; Bhadbhade, M.M.; Manoj, K. 2004: Lewis acid-promoted annulation of O-quinonediimines by allylstannane: a facile synthesis of quinoxaline derivatives. Organic Letters 6(25): 4743-4745
Pohlhaus, P.D.; Bowman, R.K.; Johnson, J.S. 2004: Lewis acid-promoted carbon-carbon bond cleavage of aziridines: divergent cycloaddition pathways of the derived ylides. Journal of the American Chemical Society 126(8): 2294-2295
Yamazaki, S.; Yamada, K.; Yamamoto, K. 2004: Lewis acid-promoted cyclization of heteroatom-substituted enynes. Organic and Biomolecular Chemistry 2(2): 257-264
Calvet, G.ér.; Dussaussois, M.; Blanchard, N.; Kouklovsky, C. 2004: Lewis acid-promoted hetero Diels-Alder cycloaddition of alpha-acetoxynitroso dienophiles. Organic Letters 6(14): 2449-2451
Lu, J.; Mao, G.; Zhang, W.; Xi, Z. 2005: Lewis acid-promoted reactions of zirconacyclopentadienes with isocyanates. a one-pot three-component synthesis of multiply-substituted iminocyclopentadienes from one isocyanate and two alkynes. Chemical Communications 38: 4848-4850
Kita, Y.; Matsuda, S.; Inoguchi, R.; Ganesh, J.K.; Fujioka, H. 2006: Lewis acid-promoted rearrangement of 2,3-epoxy alcohol derivatives: stereochemical control and selective formation of two types of chiral quaternary carbon centers from the single carbon skeleton. Journal of Organic Chemistry 71(14): 5191-5197
Nabavizadeh, S.M.; Rashidi, M. 2006: Lewis acidity of methyltrioxorhenium(VII) (MTO) based on the relative binding strengths of N-donors. Journal of the American Chemical Society 128(1): 351-357
Kawahara, S.-i.; Tsuzuki, S.; Uchimaru, T. 2005: Lewis acidity/basicity of pi-electron systems: theoretical study of a molecular interaction between a pi system and a Lewis acid/base. Chemistry 11(15): 4458-4464
Corma, A.; García, H. 2003: Lewis acids: from conventional homogeneous to green homogeneous and heterogeneous catalysis. Chemical Reviews 103(11): 4307-4365
Studt, F.; MacKay, B.A.; Johnson, S.A.; Patrick, B.O.; Fryzuk, M.D.; Tuczek, F. 2005: Lewis adducts of the side-on end-on dinitrogen-bridged complex [{(NPN)Ta}2(mu-H)2(mu-eta 1:eta 2-N2)] with AlMe3, GaMe3, and B(C6F5)3: synthesis, structure, and spectroscopic properties. Chemistry 11(2): 604-618
Britovsek, G.J.P.; Ugolotti, J.; Hunt, P.; White, A.J.P. 2006: Lewis and Brønsted multifunctionality: an unusual heterocycle from the reaction of bis(pentafluorophenyl)borinic acid with nitriles. Chemical Communications 12: 1295-1297
Lawler, F.H.; Lewis, M.; Clark, W. 2004: Lewis and Clark treat a case of paralysis: speculation on the etiology of the problem. Journal of the Oklahoma State Medical Association 97(4): 154-155
Herradón, G.; Ezquerra, L.; Morales, L.; Franklin, B.; Silos-Santiago, I.; Alguacil, L.F. 2006: Lewis and Fischer 344 strain differences in alpha2-adrenoceptors and tyrosine hydroxylase expression. Life Sciences 78(8): 862-868
Serpa, J.; Lunet, N.; Mendes, N.; Barros, H.; David, L. 2004: Lewis and Secretor status and Helicobacter pylori eradication. Epidemiology and Infection 132(5): 997
Lawler, S.D.; Marshall, R. 1961: Lewis and secretor characters in infancy. Vox Sanguinis 6: 541-554
Stratton, F. 1958: Lewis antibodies; with a note on their preservation. Bibliotheca Haematologica 7: 127-132
Nogueira, A.M.; Marques, T.; Soares, P.C.M.; David, L.; Reis, C.A.; Serpa, J.; Queiroz, D.M.; Rocha, G.A.; Rocha, A.éi.C. 2004: Lewis antigen expression in gastric mucosa of children: relationship with Helicobacter pylori infection. Journal of Pediatric Gastroenterology and Nutrition 38(1): 85-91
Denmark, S.E.; Heemstra, J.R. 2003: Lewis base activation of Lewis acids. Catalytic enantioselective addition of silyl enol ethers of achiral methyl ketones to aldehydes. Organic Letters 5(13): 2303-2306
Denmark, S.E.; Heemstra, J.R. 2006: Lewis base activation of Lewis acids. Vinylogous aldol addition reactions of conjugated N,O-silyl ketene acetals to aldehydes. Journal of the American Chemical Society 128(4): 1038-1039
Denmark, S.E.; Beutner, G.L. 2003: Lewis base activation of Lewis acids. Vinylogous aldol reactions. Journal of the American Chemical Society 125(26): 7800-7801
Denmark, S.E.; Beutner, G.L.; Wynn, T.; Eastgate, M.D. 2005: Lewis base activation of Lewis acids: catalytic, enantioselective addition of silyl ketene acetals to aldehydes. Journal of the American Chemical Society 127(11): 3774-3789
Lee, Y.; Hoveyda, A.H. 2006: Lewis base activation of grignard reagents with N-heterocyclic carbenes. Cu-free catalytic enantioselective additions to gamma-chloro-alpha,beta-unsaturated esters. Journal of the American Chemical Society 128(49): 15604-15605
Fujisawa, H.; Takahashi, E.; Mukaiyama, T. 2006: Lewis base catalyzed Mannich-type reactions between trimethylsilyl enol ethers and aldimines. Chemistry 12(19): 5082-5093
Denmark, S.E.; Chung, W.-J. 2006: Lewis base catalyzed addition of trimethylsilyl cyanide to aldehydes. Journal of Organic Chemistry 71(10): 4002-4005
Denmark, S.E.; Fujimori, S.; Pham, S.M. 2005: Lewis base catalyzed aldol additions of chiral trichlorosilyl enolates and silyl enol ethers. Journal of Organic Chemistry 70(26): 10823-10840
Minakata, S.; Okada, Y.; Oderaotoshi, Y.; Komatsu, M. 2005: Lewis base catalyzed ring opening of aziridines with silylated nucleophiles. Organic Letters 7(16): 3509-3512
Denmark, S.E.; Fan, Y.; Eastgate, M.D. 2005: Lewis base catalyzed, enantioselective aldol addition of methyl trichlorosilyl ketene acetal to ketones. Journal of Organic Chemistry 70(13): 5235-5248
Spikes, G.H.; Power, P.P. 2007: Lewis base induced tuning of the Ge-Ge bond order in a "digermyne". Chemical Communications 1: 85-87
MacFarlane, D.R.; Pringle, J.M.; Johansson, K.M.; Forsyth, S.A.; Forsyth, M. 2006: Lewis base ionic liquids. Chemical Communications 18: 1905-1917
Perez del Valle, C.; Milet, A.; Gimbert, Y.; Greene, A.E. 2005: Lewis base promoters in the Pauson-Khand reaction: a different scenario. Angewandte Chemie 44(35): 5717-5719
Schwan, K.-C.; Timoskin, A.Y.; Zabel, M.; Scheer, M. 2006: Lewis base stabilized phosphanylborane. Chemistry 12(18): 4900-4908
Lettan Ii, R.B.; Scheidt, K.A. 2005: Lewis base-catalyzed additions of alkynes using trialkoxysilylalkynes. Organic Letters 7(15): 3227-3230
Yei, C.-J.; Chang, J.-G.; Shih, M.-C.; Lin, S.-F.; Chang, C.-S.; Ko, F.-T.; Lin, K.-Y.; Liu, T.-C. 2005: Lewis blood genotypes of peptic ulcer and gastric cancer patients in Taiwan. World Journal of Gastroenterology 11(31): 4891-4894
Takahashi, J. 2005: Lewis blood group system and their antibodies (anti Le(a), anti-Le(b)). Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 675-679
Kibre, P.; Lewis Of Caerleon 1952: Lewis of Caerleon, Doctor of Medicine, astronomer, and mathematician (d. 1494?). Isis; An International Review Devoted to the History of Science and its Cultural Influences 43(132): 100-108